0001410578-22-001653.txt : 20220516 0001410578-22-001653.hdr.sgml : 20220516 20220516160813 ACCESSION NUMBER: 0001410578-22-001653 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kubient, Inc. CENTRAL INDEX KEY: 0001729750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 821808844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39441 FILM NUMBER: 22928877 BUSINESS ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (800) 409-9456 MAIL ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 10-Q 1 kbnt-20220331x10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-39441

KUBIENT, INC.

(Exact name of registrant as specified in its charter)

Delaware

82-1808844

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

500 7th Avenue, 8thFloor

New York, New York 10018

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (800) 409-9456

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, par value $0.00001 per share	KBNT	The Nasdaq Stock Market LLC
Common Stock Purchase Warrants	KBNTW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 12, 2022, the registrant had 14,303,743 shares of common stock outstanding.

Table of Contents

KUBIENT, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022

INDEX


		Page
Part I.	FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021	1
	Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021	2
	Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2022 and 2021	3
	Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021	4
	Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19
Item 4.	Controls and Procedures	20

Part II.	OTHER INFORMATION	22
Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 3.	Defaults Upon Senior Securities	22
Item 4.	Mine Safety Disclosure	22
Item 5.	Other Information	22
Item 6.	Exhibits	23
Signatures		24
Glossary		A-1

Table of Contents

Kubient, Inc.

Condensed Consolidated Balance Sheets

Item 1. Financial Statements


	March 31,		December 31,
	2022		2021
	(unaudited)
Assets
Current Assets:
Cash and cash equivalents	$	20,709,044	$	24,907,963
Accounts receivable, net		2,352,463		2,291,533
Other receivables		—		526,070
Prepaid expenses and other current assets		411,904		495,178
Total Current Assets		23,473,411		28,220,744
Intangible assets, net		2,789,625		2,946,610
Goodwill		463,000		463,000
Property and equipment, net		47,040		44,756
Deferred offering costs		10,000		10,000
Total Assets	$	26,783,076	$	31,685,110

Liabilities and Stockholders' Equity
Current Liabilities:
Accounts payable - suppliers	$	2,474,570	$	1,844,544
Accounts payable - trade		1,050,395		659,362
Accrued expenses and other current liabilities		851,800		2,493,287
Deferred revenue		26,719		395,914
Notes payable		42,066		151,336
Total Current Liabilities		4,445,550		5,544,443
Contingent consideration		23,378		613,000
Notes payable, non-current portion		77,407		77,407
Total Liabilities		4,546,335		6,234,850

Commitments and contingencies (Note 5)
Stockholders' Equity:
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2022 and December 31, 2021		—		—
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,303,743 and 14,253,948 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively		143		143
Additional paid-in capital		52,444,880		52,030,907
Accumulated deficit		(30,208,282)		(26,580,790)
Total Stockholders' Equity		22,236,741		25,450,260
Total Liabilities and Stockholders' Equity	$	26,783,076	$	31,685,110

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Kubient, Inc.

Condensed Consolidated Statements of Operations

(unaudited)


	For the Three Months Ended
	March 31,
	2022		2021

Net Revenues	$	1,245,304	$	707,757

Costs and Expenses:
Sales and marketing		1,333,010		756,950
Technology		1,155,699		519,755
General and administrative		2,182,549		1,255,572
Loss accrual on customer contract		789,605		—
Total Costs and Expenses		5,460,863		2,532,277
Loss From Operations		(4,215,559)		(1,824,520)

Other (Expense) Income:
Interest expense		(3,872)		(1,634)
Interest income		2,291		29,309
Change in fair value of contingent consideration		589,622		—
Other income		26		233
Total Other Income		588,067		27,908
Net Loss	$	(3,627,492)	$	(1,796,612)
Net Loss Per Share - Basic and Diluted	$	(0.25)	$	(0.14)
Weighted Average Common Shares Outstanding - Basic and Diluted		14,256,159		12,617,171

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Kubient, Inc.

Condensed Consolidated Statements of Changes in Stockholders' Equity

(unaudited)


	For the Three Months Ended March 31, 2022
				Additional
	Common Stock			Paid-In		Accumulated
	Shares	Amount		Capital		Deficit		Total

Balance - January 1, 2022	14,253,948	$	143	$	52,030,907	$	(26,580,790)	$	25,450,260
Surrender and cancellation of common stock	(3,397)		—		(18,683)		—		(18,683)
Stock-based compensation:
Common Stock	53,192		—		430,361		—		430,361
Options	—		—		2,295		—		2,295
Net loss	—		—		—		(3,627,492)		(3,627,492)
Balance - March 31, 2022	14,303,743	$	143	$	52,444,880	$	(30,208,282)	$	22,236,741


	For the Three Months Ended March 31, 2021
				Additional
	Common Stock			Paid-In		Accumulated
	Shares	Amount		Capital		Deficit		Total

Balance - January 1, 2021	11,756,109	$	118	$	40,770,504	$	(16,289,077)	$	24,481,545
Shares issued upon exercise of warrants, net of issuance costs [1]	2,047,361		20		9,274,891		—		9,274,911
Stock-based compensation:
Common Stock	70,040		1		513,102		—		513,103
Options	—		—		2,576		—		2,576
Net loss	—		—		—		(1,796,612)		(1,796,612)
Balance - March 31, 2021	13,873,510	$	139	$	50,561,073	$	(18,085,689)	$	32,475,523

[1]	Includes gross proceeds of $9,708,038, less issuance costs of $433,127.

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Kubient, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited)


	For the Three Months Ended
	March 31,
	2022		2021

Cash Flows From Operating Activities:
Net loss	$	(3,627,492)	$	(1,796,612)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		162,221		77,379
Change in fair value of contingent consideration		(589,622)		—
Stock-based compensation:
Common stock		429,811		2,576
Options		2,295		238,638
Changes in operating assets and liabilities:
Accounts receivable		(60,930)		913,623
Other receivable		507,387		—
Prepaid expenses and other current assets		83,274		(107,093)
Accounts payable - suppliers		630,026		(2,523)
Accounts payable - trade		391,034		(378,411)
Accrued expenses and other current liabilities		(1,532,150)		(454,018)
Accrued interest		—		1,584
Deferred revenue		(369,195)		—
Net Cash Used In Operating Activities		(3,973,341)		(1,504,857)

Cash Flows From Investing Activities:
Purchase of intangible assets		—		(64,072)
Purchase of property and equipment		(7,520)		(1,882)
Net Cash Used In Investing Activities		(7,520)		(65,954)

Cash Flows From Financing Activities:
Proceeds from exercise of warrants [1]		—		9,326,163
Repayment of PPP loan		(109,270)		—
Repayment of financed director and officer insurance premiums		(108,788)		—
Net Cash (Used In) Provided By Financing Activities		(218,058)		9,326,163
Net (Decrease) Increase In Cash and Cash Equivalents		(4,198,919)		7,755,352
Cash and Cash Equivalents - Beginning of the Period		24,907,963		24,782,128
Cash and Cash Equivalents - End of the Period	$	20,709,044	$	32,537,480

[1]	Includes gross proceeds of $9,708,038, less issuance costs of $381,875.

Table of Contents

Kubient, Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

(unaudited)


	For the Three Months Ended
	March 31,
	2022		2021

Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for:
Interest	$	—	$	—
Income taxes	$	—	$	—

Non-cash investing and financing activities:
Surrender and cancellation of common stock	$	(18,683)	$	—
Shares of common stock issued in satisfaction of accrued issuable equity	$	—	$	500,400
Accrual of issuance costs	$	—	$	51,252

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Risks and Uncertainties

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company's operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of March 31, 2022 and for the three months ended March 31, 2022 and 2021. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2021 and 2020 and for the years then ended which are included the Annual Report filed on Form 10-K on March 31, 2022.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2021 and 2020 and for the years then ended, which were included the Annual Report filed on Form 10-K on March 31, 2022, except as disclosed in this note.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of March 31, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2022, the Company recognized $395,914 of revenue that was deferred as of December 31, 2021. As of March 31, 2022 and December 31, 2021, the Company had $0 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the three months ended March 31, 2022 and 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:


	For the Three Months Ended
	March 31,
	2022	2021
Warrants [1]	5,122,074	5,234,721
Restricted stock units	855,989	—
Restricted stock awards	307,791	—
Stock options	94,447	117,261
	6,380,301	5,351,982

[1] The 2022 period includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.The 2021 period includes shares underlying warrants that are exercisable into an aggregate of (i) 462,997 shares of common stock and (ii) five-year warrants to purchase 462,997 shares of common stock at an exercise price of $5.50 per share.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 3 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:


	March 31,		December 31,
	2022		2021
Accrued bonuses	$	—	$	554,997
Accrued payroll		13,750		13,750
Financed director and officer insurance premiums		108,788		217,575
Accrued supplier expenses		96,744		67,971
Accrued legal settlement		—		975,000
Accrued legal and professional fees		155,530		20,323
Accrued commissions		3,681		36,109
Accrued media commissions		47,925		138,028
Credit card payable		276,724		328,075
Accrued programming expenses		—		1,750
Accrued issuable equity		708		1,258
Accrued interest		7,725		9,017
Accrued warrant exercise costs		83,519		83,519
Other		24,571		45,915
Total accrued expenses and other current liabilities	$	819,665	$	2,493,287

NOTE 4 – STOCKHOLDERS’ EQUITY

Stock-Based Compensation

For the three months ended March 31, 2022 and 2021, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows:


	For the Three Months Ended
	March 31,
	2022		2021
Sales and marketing	$	35,581	$	220,508
Technology		78,875		2,863
General and administrative		317,650		17,843
Total	$	432,106	$	241,214

As of March 31, 2022, there was approximately $1,983,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 3.4 years.

During the three months ended March 31, 2022, the Company granted 53,192 shares of immediately vested restricted stock awards (“RSAs”) to non-employee directors under the Kubient, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) with an aggregate grant date fair value of $100,000 that was recognized immediately.

During the three months ended March 31, 2022, the Company issued 100,000 RSAs, 489,990 restricted stock units (“RSUs”) and a target number of 234,376 performance stock units (“PSUs”), all issued under the 2021 Plan. The RSAs and RSUs generally vest over four years and the PSUs are earned based upon based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,900,000.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Common Stock

During the three months ended March 31, 2022, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock, which were subsequently cancelled by the Company, in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.

NOTE 5 – FAIR VALUE MEASUREMENT

On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). The Earnout Shares had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.

On March 31, 2022, the Company recomputed the fair value of its Earnout Shares as $26,719 using the Monte Carlo simulation. The Company recorded a gain on the change in fair value of the contingent consideration of $589,622 during the three months ended March 31, 2022.

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:


Contingent Consideration
Beginning balance as of January 1, 2022	$	613,000
Change in fair value of contingent consideration		(589,622)
Ending balance as of March 31, 2022	$	23,378

NOTE 6 – COMMITMENTS AND CONTINGENCIES

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

Settlement Agreement

On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”). Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment in the three months ended March 31, 2022 of $975,000 to Lo70s in consideration of the dismissal of the ligation among the parties, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the Lo70s Settlement Agreement. During the year ended December 31, 2021, the Company recognized a loss on settlement of approximately $875,000 such that, as of December 31, 2021, it had accrued for the $975,000 cash payment.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 7 – CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:


	For the Three Months Ended
	March 31,
Customer	2022		2021
Customer A	42.02	%	102.40	%
Customer B	43.25	%	N/A
Total	85.27	%	102.40	%

* Less than 10%.

From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:


	March 31,		December 31,
Customer	2022		2021
Customer A	15.98	%	22.08	%
Customer B	23.13	%	*
Customer E	19.04	%	*
Customer F	27.99	%	52.18	%
Total	86.13	%	74.26	%

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:


	For the Three Months Ended
	March 31,
Supplier	2022		2021
Supplier A	18.77	%	*
Supplier B	*		18.10	%
Supplier C	23.84	%	N/A
Supplier D	17.56	%	N/A
Supplier E	N/A		16.2	%
Supplier F	*		15.0	%
Supplier G	14.40	%	N/A
Total	74.56	%	49.30	%

* Less than 10%.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operating performance and may include statements concerning, among other things, our business strategy (including anticipated trends and developments in, and management plans for, our business and the markets in which we operate), financial results, the impact of COVID-19 on our business, operations, and the markets and communities in which we, our clients, and partners operate, results of operations, revenues, operating expenses, and capital expenditures, sales and marketing initiatives and competition. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “suggests,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These statements are not guarantees of future performance; they reflect our current views with respect to future events and are based on assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from expectations or results projected or implied by forward-looking statements.

We discuss many of these risks in other filings we make from time to time with the Securities and Exchange Commission (the “SEC”). Also, these forward-looking statements represent our estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q, which are inherently subject to change and involve risks and uncertainties. Unless required by federal securities laws, we assume no obligation to update any of these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated, to reflect circumstances or events that occur after the statements are made. Given these uncertainties, investors should not place undue reliance on these forward-looking statements.

Investors should read this Quarterly Report on Form 10-Q and the documents that we reference in this report and have filed with the SEC, including our Annual Report on Form 10-K, filed with the SEC on March 31, 2022, with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Unless the context requires otherwise, references to the “Company,” “Kubient,” “we,” “us” and “our” refer to Kubient, Inc., a Delaware corporation and its wholly-owned subsidiary, Fidelity Media, LLC, a Delaware limited liability company. For explanations of certain terms used in this prospectus, please read “Glossary” beginning on page A-1.

Overview

Kubient, Inc. (“Kubient,” “we,” “our,” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection & prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. Most importantly, it’s self-learning, getting smarter and more accurate over time. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

Table of Contents

Russian Sanctions

The current invasion of Ukraine by Russia has escalated tensions among the United States, the North Atlantic Treaty Organization (“NATO”) and Russia. The United States and other NATO member states, as well as non-member states, have announced new sanctions against Russia and certain Russian banks, enterprises and individuals. Violation of such sanctions could result in civil and criminal, monetary and non-monetary penalties, disruptions to our business, limitations on our ability to import and export products and services, and damage to our reputation. As a result, the Company had terminated 10 contractors performing software engineering services as of March 25, 2022. As a result, the Company does not currently employ or contract with any engineers located in Russia. The current political climate has reduced the available number of engineers for hire in such regions. Furthermore, on-going conflict in Ukraine and the spread of political tensions in surrounding areas could increase the threat of cyberwarfare as well as wide-spread internet service interruptions, which would likely disrupt or delay the operations of many digitally-focused companies such as our own.

COVID-19

Table of Contents

Results of Operations

Three Months Ended March 31, 2022 Compared With Three Months Ended March 31, 2021

The following table presents the results of operations for the three months ended March 31, 2022 and 2021:


	For the Three Months Ended
	March 31,
	2022		2021

Net Revenues	$	1,245,304	$	707,757

Costs and Expenses:
Sales and marketing		1,333,010		756,950
Technology		1,155,699		519,755
General and administrative		2,182,549		1,255,572
Loss accrual on customer contract		789,605		—
Total Costs and Expenses		5,460,863		2,532,277
Loss From Operations		(4,215,559)		(1,824,520)

Other (Expense) Income:
Interest expense		(3,872)		(1,634)
Interest income		2,291		29,309
Change in fair value of contingent consideration		589,622		—
Other income		26		233
Total Other Income		588,067		27,908
Net Loss	$	(3,627,492)	$	(1,796,612)

Net Revenues

For the three months ended March 31, 2022, net revenues increased by $537,547, or 76%, to $1,245,304 from $707,757 for the three months ended March 31, 2021. The increase in net revenues is primarily attributable to net revenues generated related to customer contracts acquired in connection with our acquisition of MediaCrossing in November 2021.

See Loss Accrual on Customer Contract for a discussion of an estimated loss accrual recorded during the three months ended March 31, 2022 associated with a contract with a customer.

Sales and Marketing

For the three months ended March 31, 2022, sales and marketing expenses increased by $576,060, or 76%, to $1,333,010 from $756,950 for the three months ended March 31, 2021. The increase is primarily due to an increase in headcount costs of approximately $800,000, partially offset by a decrease in non-cash stock-based compensation of approximately $185,000 as well as a reduction in selling expense of approximately $40,000.

Technology

For the three months ended March 31, 2022, technology expenses increased by $635,944, or 122%, to $1,155,669 from $519,755 for the three months ended March 31, 2021. The increase is primarily due to an increase in headcount costs of approximately $274,000, hosting fees of approximately $175,000, non-cash stock-based compensation of approximately $76,000, amortization of approximately $81,000 and software expenses of approximately $33,000.

Table of Contents

General and Administrative

For the three months ended March 31, 2022, general and administrative expenses increased by $926,977, or 74%, to $2,182,549 from $1,255,572 for the three months ended March 31, 2021. The increase is primarily due to increases of legal fees of approximately $515,000, non-cash stock-based compensation of approximately $300,000, other professional fees of approximately $82,000, rent expenses of approximately $47,000, director fees of approximately $33,000, partially offset by a reduction in state taxes of approximately $74,000.

Loss Accrual on Customer Contract

During the three months ended March 31, 2022, we recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer. We will continue to monitor this loss accrual going forward. Subsequent to March 31, 2022, we recovered approximately $139,000 associated with this loss.

Other Income

For the three months ended March 31, 2022, other income increased by $560,159, or 2,007%, to $588,067 from $27,908 for the three months ended March 31, 2021. The increase is primarily due to a gain recognized related to a decrease in the fair value of the earnout shares issuable to MediaCrossing.

Non-GAAP Measures

Adjusted EBITDA

The Company defines EBITDA as net income (loss) before interest, taxes and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, further adjusted to eliminate the impact of certain non-recurring items and other items that we do not consider in our evaluation of our ongoing operating performance from period to period. These items will include stock-based compensation, restructuring and severance costs, transaction costs, acquisition costs, certain other non-recurring charges and gains that the Company does not believe reflects the underlying business performance.

For the three months ended March 31, 2022 and 2021, EBITDA and Adjusted EBITDA consisted of the following:


	For the Three Months Ended
	March 31,
	2022		2021
Net Loss	$	(3,627,492)	$	(1,796,612)
Interest expense		3,872		1,634
Interest income		(2,291)		(29,309)
Depreciation and amortization		162,221		77,379
EBITDA		(3,463,690)		(1,746,908)

Adjustments:
Stock-based compensation expense		432,656		241,214
Change in fair value of contingent consideration		(589,622)		—
Adjusted EBITDA	$	(3,620,656)	$	(1,505,694)

Adjusted Loss Per Share	$	(0.25)	$	(0.12)
Weighted Average Common Shares Outstanding -
Basic and Diluted		14,256,159		12,617,171

EBITDA and Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (a) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s

Table of Contents

core operating results over time (such as stock-based compensation expense), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. The Company’s management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.

Liquidity and Capital Resources

We measure our liquidity in a number of ways, including the following:


	March 31,		December 31,
	2022		2021
	(unaudited)
Cash and cash equivalents	$	20,709,044	$	24,907,963
Working capital	$	19,027,861	$	22,676,301

Availability of Additional Funds

As a result of its public offerings and the related note conversions, the Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings.

Cash Flows

Three Months Ended March 31, 2022 Compared With Three Months Ended March 31, 2021

Our sources and uses of cash were as follows:

Cash Flows From Operating Activities

We experienced negative cash flows from operating activities for the three months ended March 31, 2022 and 2021 in the amounts of $3,973,341 and $1,504,857, respectively. The net cash used in operating activities for the three months ended March 31, 2022 was primarily a result of cash used to fund a net loss of $3,627,492, adjusted for net non-cash expenses of $4,705, and $350,554 of net cash used in changes in the levels of operating assets and liabilities. The net cash used in operating activities for the three months ended March 31, 2021 was primarily a result of cash used to fund a net loss of $1,796,612, adjusted for non-cash expenses of $318,593, and $26,838 of net cash used in changes in the levels of operating assets and liabilities.

Table of Contents

Cash Flows From Investing Activities

Net cash used in investing activities for the three months ended March 31, 2022 was $7,520, which was attributable to purchases of property and equipment. Net cash used in investing activities for the three months ended March 31, 2021 was $65,954, which was attributable to purchases of intangible assets and property and equipment.

Cash Flows From Financing Activities

Net cash used in financing activities for the three months ended March 31, 2022 was $218,058, which was attributable to repayments of our PPP loan of $109,270 as well as repayments of financed director and officer insurance premiums of $108,788. Net cash provided by financing activities for the three months ended March 31, 2021 was $9,326,163, which was provided by the exercise of warrants.

Off-Balance Sheet Arrangements

We did not have, during the periods presented, and we do not currently have, any relationships with any organizations or financial partnerships, such as structured finance or special purpose entities, that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Contractual Obligations

As a smaller reporting company, we are not required to provide the information required by paragraph (a)(5) of this Item.

Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, contingent assets and liabilities, each as of the date of the financial statements, and revenues and expenses during the periods presented. On an ongoing basis, management evaluates their estimates and assumptions, and the effects of any such revisions are reflected in the financial statements in the period in which they are determined to be necessary. Management bases their estimates on historical experience and on various other factors that they believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual outcomes could differ materially from those estimates in a manner that could have a material effect on our consolidated financial statements. While our significant accounting policies are more fully described in the notes to our consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies and estimates are critical to the process of making significant judgments and estimates in the preparation of our financial statements and understanding and evaluating our reported financial results.

Revenue Recognition

Table of Contents

risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

Business Combinations

Business combinations are accounted for using the acquisition method and, accordingly, the assets acquired (including identified intangible assets), the liabilities assumed and any contingent consideration are recorded at their acquisition date fair values. The Company’s fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect the Company’s own assumptions in measuring fair value.

Intangible Assets

Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount.

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

Not applicable to smaller reporting companies.

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of March 31, 2022. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures, and is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Based on this evaluation, and as a result of the material weakness described below, our CEO and CFO have concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of March 31, 2022. In light of this fact, our management has performed additional analyses, reconciliations, and other post-closing procedures and has concluded that, notwithstanding the material weaknesses in our internal control over financial reporting, the unaudited interim condensed consolidated financial statements for the periods covered by and included in this Quarterly Report on Form 10-Q fairly state, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.

Material Weakness

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. The following material weakness in our internal control over financial reporting was identified as part of management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2021 and continued to exist as of March 31, 2022:

●

The Company had inadequate segregation of duties in its finance and accounting function because of its limited personnel.

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. These deficiency listed above, combined with inadequate compensating controls, created a reasonable possibility that a material misstatement to the consolidated financial statements might not be prevented or detected on a timely basis.

Management expects to remediate these control deficiencies during 2022, including by expanding the number of personnel in its finance and accounting department.

Changes in Internal Control over Financial Reporting

During the quarter ended March 31, 2022, management continued to implement improvements to the Company’s internal control system. The Company’s process included:

●

The Company continued its engagement with outside advisory and consulting firms with expertise in evaluating and remediating material weaknesses in internal control over financial reporting.

●

The gaps identified as a result of the Company’s testing of operational effectiveness in its business processes were used to further evaluate and test the adequacy of design.

●

The redesigned business processes began to operate effectively.

Except as described above, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of the legal proceedings set forth herein may result in adverse decisions or settlements, Management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows.

In addition, the following material legal proceeding was recently settled:

On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”). Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. On March 14, 2022, the court in the matter entered an order approving the Lo70s Settlement Agreement, and the case was dismissed with prejudice. In the Lo70s Settlement Agreement, the Company expressly denies any and all liability and the dismissal of the case with prejudice was entered by the court without a final judgment of liability entered against the Company. Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment of $975,000 to Lo70s in the three months ended March 31, 2022 in full satisfaction of the matter, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the agreement, such that the Lo70s Settlement Agreement fully concludes this matter.

Item 1A. Risk Factors.

Not applicable to smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosure.

Not applicable.

Item 5. Other Information.

There is no other information required to be disclosed under this item which was not previously disclosed.

Table of Contents

Item 6. Exhibits


Exhibit Number	Exhibit Description	Incorporated by Reference			Filed Herewith
		Form	Filing Date	Exhibit Number
31.1	Certification of Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X

31.2	Certification of Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X

32.1 *	Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)				X

101.ins	XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.				X

101.sch	Inline XBRL Taxonomy Schema Document				X

101.cal	Inline XBRL Taxonomy Calculation Linkbase Document				X

101.def	Inline XBRL Taxonomy Definition Linkbase Document				X

101.lab	Inline XBRL Taxonomy Label Linkbase Document				X

101.pre	Inline XBRL Taxonomy Presentation Linkbase Document				X
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)				X

*This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and it is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	KUBIENT, INC.

Dated: May 16, 2022	/s/ Paul Roberts
	Paul Roberts
	Chief Executive Officer
	(principal executive officer)


Dated: May 16, 2022	/s/ Joshua Weiss
	Joshua Weiss
	Chief Financial Officer
	(principal financial and accounting officer)

Table of Contents

GLOSSARY

“Ad network” means an intermediary network or company that acts as a broker between advertisers who want to purchase ad placements and content publishers who want to host the advertiser’s ads. Examples of advertisers are consumer good companies, multimedia companies and automobile manufacturers. Publishers in the context are website operators or app developers.

“Audience Marketplace” means the modular, highly scalable, transparent, cloud-based software platform created by the Company for real-time trading of digital, Programmatic Advertising.

“Bot” or “internet bot” means an autonomous program (or robot) running on a network (usually, the internet) that can interact with computer systems or users. Typically, Bots perform tasks that are both simple and structurally repetitive, at a much higher rate than would be possible for a human alone. According to Imperva, more than half of all web traffic is fraudulent, as it is made up of Bots rather than actual human beings.

“Brand” means a particular name used to identify a type of product or products manufactured by a particular company.

“Demand Side Platform” or “DSP” means a system that allows buyers of digital advertising space (ie, advertisers) to manage multiple ad exchange and data exchange accounts through one interface.

“Full stack” means computer engineering that encompasses databases, servers, systems engineering, and clients, across mobile applications, web-based applications and native applications.

“Latency” means the lag time between a customer click on an internet link and the conversion of that customer to a sale. The term can also refer to the lag time between ad inventory’s purchase and its display on publisher’s media.

“Omni-channel marketing” means marketing that is intended to reach target consumers across all advertising channels — mobile, video, desktop, and more — within the context of how the specific customer has interacted with a brand (for example, those first seeing an ad about a brand they have never experienced will receive a different message from those who have engaged with that brand a number of times).

“Programmatic advertising” means the purchase of advertising space meant to target audiences using software and tools that help agencies and brands target, deliver, and analyze their digital advertising efforts., rather than the traditional method of purchasing time slots in mass media, such as television programming.

“Pre-bid” means the bid placed by an advertiser for placement of its ad, verified prior to such ad being run or displayed.

“Post-bid” means the verification of the running or display of an ad, after such running or display has occurred.

“Publisher” means a source of ad inventory, such as website owners, website operators or app developers. Publishers are generally either managed or owned and operated. An owned and operated publisher receives 100% of the profit for impressions sold. This is opposed to a managed publisher: a publisher that does not own its inventory but has a financial relationship with those who do.

“Supply Side Platform” or “SSP” means a platform that enables Publishers to access advertiser demand from a variety of networks, exchanges, and platforms via one interface.

“300-millisecond window” means the window of time adopted by the digital advertising industry in which a website or app has to load the content on their website and auction off the advertising space on their web property.

A-1

EX-31.1 2 kbnt-20220331xex31d1.htm EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul Roberts, certify that:

1.	I have reviewed this annual report on Form 10-Q of Kubient, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 16, 2022

/s/ Paul Roberts

Paul Roberts

Chief Executive Officer

(principal executive officer)

EX-31.2 3 kbnt-20220331xex31d2.htm EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Joshua Weiss, certify that:

1.	I have reviewed this annual report on Form 10-Q of Kubient, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 16, 2022

/s/ Joshua Weiss

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer)

EX-32.1 4 kbnt-20220331xex32d1.htm EX-32.1

Exhibit 32.1

Certifications of Principal Executive Officer and Principal Financial Officer

pursuant to

18 U.S.C. Section 1350,

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Paul Roberts, Chief Executive Officer (principal executive officer) of Kubient, Inc. (the “Company”), and Joshua Weiss, Chief Financial Officer (principal financial and accounting officer) of the Company, each hereby certifies that, to the best of his knowledge:

The Company’s Annual Report on Form 10-Q for the quarter ended March 31, 2022, to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 16, 2022

/s/ Paul Roberts

Paul Roberts

Chief Executive Officer

(principal executive officer)

/s/ Joshua Weiss

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer)

The foregoing certifications are being furnished pursuant to 18 U.S.C. Section 1350. They are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.

GRAPHIC 5 kbnt-20220331x10q001.jpg GRAPHIC begin 644 kbnt-20220331x10q001.jpg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end EX-101.SCH 6 kbnt-20220331.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation Default (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - FAIR VALUE MEASUREMENT (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - FAIR VALUE MEASUREMENT - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES - Settlements (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - FAIR VALUE MEASUREMENT link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - FAIR VALUE MEASUREMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 kbnt-20220331_cal.xml EX-101.CAL EX-101.DEF 8 kbnt-20220331_def.xml EX-101.DEF EX-101.LAB 9 kbnt-20220331_lab.xml EX-101.LAB Document and Entity Information [Abstract] Document Information [Table] Equity Components [Axis] Equity Component [Domain] Common Stock Warrants Document Information [Line Items] Document Type Document Quarterly Report Document Transition Report Document Period End Date Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Adress Line Two Entity Address, City or Town Entity Address State Or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Assets Current Assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable, net Accounts and Other Receivables, Net, Current Other receivables Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total Current Assets Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Goodwill Goodwill Property, Plant and Equipment, Net Property and equipment, net Deferred Costs, Noncurrent Deferred offering costs Assets. Total Assets Liabilities and Stockholders' Deficiency Liabilities and Stockholders' Equity Current Liabilities: Carrying value as of the balance sheet date of obligations incurred and payable to supplier for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accounts Payable, Supplier, Current Accounts payable - suppliers Accounts Payable, Trade, Current Accounts payable - trade Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other other than interest payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued And Other Liabilities, Current, Other Than Interest Payable Accrued expenses and other current liabilities Deferred Revenue, Current Deferred revenue Notes Payable, Current Notes payable Liabilities, Current Total Current Liabilities Business Combination, Contingent Consideration, Liability, Noncurrent Contingent consideration Notes Payable, Noncurrent Notes payable, non-current portion Liabilities Total Liabilities Commitments and Contingencies Commitments and contingencies (Note 5) Stockholders' Deficiency: Stockholders' Equity : Preferred Stock, Value, Issued Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2022 and December 31, 2021 Common Stock, Value, Issued Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,303,743 and 14,253,948 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Balance at the end Balance at the beginning Total Stockholders' Equity Liabilities and Equity Total Liabilities and Stockholders' Equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Condensed Consolidated Statements of Operations Revenue from Contract with Customer, Including Assessed Tax Net Revenues Operating Expenses [Abstract] Costs and Expenses: Selling and Marketing Expense Sales and marketing Communications and Information Technology Technology General and Administrative Expense General and administrative Amount represents loss accrual on customer contract. Loss Accrual On Customer Contract Gain (Loss) Related to Litigation Settlement Loss on legal settlement Loss on legal settlement Operating Expenses Total Costs and Expenses Operating Income (Loss) Loss From Operations Nonoperating Income (Expense) [Abstract] Other (Expense) Income: Interest Expense Interest expense Interest Income, Other Interest income Represents the amount of change in fair value of contingent consideration. Change In Fair Value Of Contingent Consideration Change in fair value of contingent consideration Change in fair value of contingent consideration Other Nonoperating Income Other income Nonoperating Income (Expense) Total Other Income Net Income (Loss) Attributable to Parent Net loss Net Loss Net Income (Loss) Available to Common Stockholders, Basic Net Loss Attributable to Common Shareholders Earnings Per Share, Basic Net Loss Per Share - Basic Earnings Per Share, Diluted Net Loss Per Share - Diluted Weighted Average Number of Shares Outstanding, Basic Weighted Average Common Shares Outstanding - Basic Weighted Average Number of Shares Outstanding, Diluted Weighted Average Common Shares Outstanding - Diluted Condensed Consolidated Statements of Changes in Stockholders' Equity Statement [Table] Additional Paid-In Capital Accumulated Deficit Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares, Outstanding Balance at the end (in shares) Balance at the beginning (in shares) Represents the amount of shares issued and forfeited during the period. Shares Issued and Forfeited During The Period Value Surrender and cancellation of common stock Represents the number of shares issued and forfeited during the period. Shares Issued and Forfeited During The Period Shares Surrender and cancellation of common stock (in shares) Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Stock-based compensation: Common stock Common stock aggregate issuance date fair value Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Stock-based compensation: Common stock (in shares) Number of shares issued under share based compensation plan APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Stock-based compensation: Options The amount of value of shares issued upon exercise of warrants, net of issuance costs. Shares Issued Value Upon Exercise Of Warrants Net Of Issuance Costs Shares issued upon exercise of warrants, net of issuance costs The number of shares issued upon exercise of warrants, net of issuance costs . Shares Issued Shares Upon Exercise Of Warrants Net Of Issuance Costs Shares issued upon exercise of warrants, net of issuance costs (in shares) The gross cash inflow associated with the amount received from entity's first offering of stock to the public, before deduction of offering costs. Gross Proceeds from Issuance Initial Public Offering Gross proceeds from initial public offering Payments of Financing Costs Issuance costs from exercise of warrants Issuance costs on initial public offering Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows From Operating Activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Restricted Stock or Unit Expense Stock-based compensation: Common stock The amount of stock options plan expense. Stock Options Plan Expense Stock-based compensation: Options Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Accounts and Other Receivables Other receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Change in recurring obligations of a business that arise from the acquisition of supplies used in the production and sale of goods and services. Increase (Decrease) in Accounts Payable, Suppliers Accounts payable - suppliers Increase (Decrease) in Accounts Payable, Trade Accounts payable - trade Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other current liabilities Increase (Decrease) in Interest Payable, Net Accrued interest Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities Net Cash Used In Operating Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows From Investing Activities: Payments to Acquire Intangible Assets Purchase of intangible assets Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Net Cash Provided by (Used in) Investing Activities Net Cash Used In Investing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows From Financing Activities: Proceeds from Warrant Exercises Proceeds from exercise of warrants [1] Repayments of Debt Repayment of PPP loan The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Repayment Of Financed Director And Officer Insurance Premiums Repayment of financed director and officer insurance premiums Net Cash Provided by (Used in) Financing Activities Net Cash (Used In) Provided By Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (Decrease) Increase In Cash and Cash Equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and Cash Equivalents - End of the Period Cash and Cash Equivalents - Beginning of the Period Supplemental Cash Flow Elements [Abstract] Supplemental Disclosures of Cash Flow Information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non-cash investing and financing activities: Stock Issued Shares of common stock issued in satisfaction of accrued issuable equity Amount of accrual of issuance costs. Accrual Of Issuance Costs Accrual of issuance costs The gross cash inflow from issuance of convertible notes payable and investor warrants. Gross Proceeds From Convertible Notes Payable and Investor Warrants Gross proceeds from initial public offering The cash outflow from payments of offering costs for issuance of convertible notes payable and investor warrants. Payments Of Offering Costs for Issuance of Convertible Notes Payable and Investor Warrants Payments of offering costs for initial public offering BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY FAIR VALUE MEASUREMENT Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENT COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES CONCENTRATIONS Concentration Risk Disclosure [Text Block] CONCENTRATIONS Revenue [Policy Text Block] Revenue Recognition Earnings Per Share, Policy [Policy Text Block] Net Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of calculation of weighted average dilutive common shares Tabular disclosure of the accrued expenses and other current liabilities . Schedule Accrued Expenses And Other Current Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock based compensation expense related to stock options and common stock Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Summary of changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Summary of customer and supplier concentrations Disaggregation of Revenue [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum Maximum Disaggregation of Revenue [Line Items] Invoice payment terms. Invoice Payment Terms Invoice payment terms Energy Marketing Contract Liabilities, Current Contract liabilities Deferred Income, Current Deferred revenue recognized by the company Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Revenue recognized from performance obligations satisfaction period Revenue, Remaining Performance Obligation, Amount Revenue recognized from performance obligations satisfied Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Restricted stock units (RSUs) Restricted stock awards Stock options Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss Per Common Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares excluded from the calculation of weighted average dilutive common shares Number of warrants exercisable in to shares of common stock. Class of Warrant or Right, Number of Warrants Exercisable Number of warrants exercisable (in shares) EX-101.PRE 10 kbnt-20220331_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2022	May 12, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Entity File Number	001-39441
Entity Registrant Name	Kubient, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-1808844
Entity Address, Address Line One	500 7th Avenue,
Entity Address, Adress Line Two	8th Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	800
Local Phone Number	409-9456
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,303,743
Entity Central Index Key	0001729750
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.00001 per share
Trading Symbol	KBNT
Security Exchange Name	NASDAQ
Warrants
Document Information [Line Items]
Title of 12(b) Security	Common Stock Purchase Warrants
Trading Symbol	KBNTW
Security Exchange Name	NASDAQ

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 20,709,044	$ 24,907,963
Accounts receivable, net	2,352,463	2,291,533
Other receivables		526,070
Prepaid expenses and other current assets	411,904	495,178
Total Current Assets	23,473,411	28,220,744
Intangible assets, net	2,789,625	2,946,610
Goodwill	463,000	463,000
Property and equipment, net	47,040	44,756
Deferred offering costs	10,000	10,000
Total Assets	26,783,076	31,685,110
Current Liabilities:
Accounts payable - suppliers	2,474,570	1,844,544
Accounts payable - trade	1,050,395	659,362
Accrued expenses and other current liabilities	851,800	2,493,287
Deferred revenue	26,719	395,914
Notes payable	42,066	151,336
Total Current Liabilities	4,445,550	5,544,443
Contingent consideration	23,378	613,000
Notes payable, non-current portion	77,407	77,407
Total Liabilities	4,546,335	6,234,850
Commitments and contingencies (Note 5)
Stockholders' Equity :
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2022 and December 31, 2021
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,303,743 and 14,253,948 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	143	143
Additional paid-in capital	52,444,880	52,030,907
Accumulated deficit	(30,208,282)	(26,580,790)
Total Stockholders' Equity	22,236,741	25,450,260
Total Liabilities and Stockholders' Equity	$ 26,783,076	$ 31,685,110

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Condensed Consolidated Balance Sheets
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	95,000,000	95,000,000
Common stock, shares issued	14,303,743	14,253,948
Common stock, shares outstanding	14,303,743	14,253,948

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Condensed Consolidated Statements of Operations
Net Revenues	$ 1,245,304	$ 707,757
Costs and Expenses:
Sales and marketing	1,333,010	756,950
Technology	1,155,699	519,755
General and administrative	2,182,549	1,255,572
Loss Accrual On Customer Contract	789,605
Total Costs and Expenses	5,460,863	2,532,277
Loss From Operations	(4,215,559)	(1,824,520)
Other (Expense) Income:
Interest expense	(3,872)	(1,634)
Interest income	2,291	29,309
Change in fair value of contingent consideration	589,622
Other income	26	233
Total Other Income	588,067	27,908
Net Loss	$ (3,627,492)	$ (1,796,612)
Net Loss Per Share - Basic	$ (0.25)	$ (0.14)
Net Loss Per Share - Diluted	$ (0.25)	$ (0.14)
Weighted Average Common Shares Outstanding - Basic	14,256,159	12,617,171
Weighted Average Common Shares Outstanding - Diluted	14,256,159	12,617,171

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)

Common Stock

Additional Paid-In Capital

Accumulated Deficit

Total

Balance at the beginning at Dec. 31, 2020

$ 118

$ 40,770,504

$ (16,289,077)

$ 24,481,545

Balance at the beginning (in shares) at Dec. 31, 2020

11,756,109

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock-based compensation: Common stock

$ 1

513,102

513,103

Stock-based compensation: Common stock (in shares)

70,040

Stock-based compensation: Options

2,576

Shares issued upon exercise of warrants, net of issuance costs

^[1]

$ 20

9,274,891

9,274,911

Shares issued upon exercise of warrants, net of issuance costs (in shares)

^[1]

2,047,361

Net loss

(1,796,612)

Balance at the end at Mar. 31, 2021

$ 139

50,561,073

(18,085,689)

32,475,523

Balance at the end (in shares) at Mar. 31, 2021

13,873,510

Balance at the beginning at Dec. 31, 2021

$ 143

52,030,907

(26,580,790)

25,450,260

Balance at the beginning (in shares) at Dec. 31, 2021

14,253,948

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Surrender and cancellation of common stock

(18,683)

Surrender and cancellation of common stock (in shares)

(3,397)

Stock-based compensation: Common stock

430,361

Stock-based compensation: Common stock (in shares)

53,192

Stock-based compensation: Options

2,295

Net loss

(3,627,492)

Balance at the end at Mar. 31, 2022

$ 143

$ 52,444,880

$ (30,208,282)

$ 22,236,741

Balance at the end (in shares) at Mar. 31, 2022

14,303,743

[1]	Includes gross proceeds of $9,708,038, less issuance costs of $433,127.

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)	3 Months Ended
	Mar. 31, 2022 USD ($)
Condensed Consolidated Statements of Changes in Stockholders' Equity
Gross proceeds from initial public offering	$ 9,708,038
Issuance costs on initial public offering	$ 433,127

XML 17 R7.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows - USD ($)

3 Months Ended

Mar. 31, 2022

Mar. 31, 2021

Cash Flows From Operating Activities:

Net loss

$ (3,627,492)

$ (1,796,612)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

162,221

77,379

Change in fair value of contingent consideration

(589,622)

Stock-based compensation: Common stock

429,811

2,576

Stock-based compensation: Options

2,295

238,638

Changes in operating assets and liabilities:

Accounts receivable

(60,930)

913,623

Other receivable

507,387

Prepaid expenses and other current assets

83,274

(107,093)

Accounts payable - suppliers

630,026

(2,523)

Accounts payable - trade

391,034

(378,411)

Accrued expenses and other current liabilities

(1,532,150)

(454,018)

Accrued interest

1,584

Deferred revenue

(369,195)

Net Cash Used In Operating Activities

(3,973,341)

(1,504,857)

Cash Flows From Investing Activities:

Purchase of intangible assets

(64,072)

Purchase of property and equipment

(7,520)

(1,882)

Net Cash Used In Investing Activities

(7,520)

(65,954)

Cash Flows From Financing Activities:

Proceeds from exercise of warrants [1]

^[1]

9,326,163

Repayment of PPP loan

(109,270)

Repayment of financed director and officer insurance premiums

(108,788)

Net Cash (Used In) Provided By Financing Activities

(218,058)

9,326,163

Net (Decrease) Increase In Cash and Cash Equivalents

(4,198,919)

7,755,352

Cash and Cash Equivalents - Beginning of the Period

24,907,963

24,782,128

Cash and Cash Equivalents - End of the Period

20,709,044

32,537,480

Non-cash investing and financing activities:

Surrender and cancellation of common stock

$ (18,683)

Shares of common stock issued in satisfaction of accrued issuable equity

500,400

Accrual of issuance costs

$ 51,252

[1]	Includes gross proceeds of $9,708,038, less issuance costs of $381,875.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Parenthetical)	3 Months Ended
	Mar. 31, 2022 USD ($)
Condensed Consolidated Statements of Cash Flows
Gross proceeds from initial public offering	$ 9,708,038
Payments of offering costs for initial public offering	$ 381,875

XML 19 R9.htm IDEA: XBRL DOCUMENT

BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2022

BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

Organization and Operations

Risks and Uncertainties

Basis of Presentation

XML 20 R10.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2022

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Net Loss Per Common Share


	For the Three Months Ended
	March 31,
	2022	2021
Warrants [1]	5,122,074	5,234,721
Restricted stock units	855,989	—
Restricted stock awards	307,791	—
Stock options	94,447	117,261
	6,380,301	5,351,982

XML 21 R11.htm IDEA: XBRL DOCUMENT

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

3 Months Ended

Mar. 31, 2022

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

NOTE 3 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:


	March 31,		December 31,
	2022		2021
Accrued bonuses	$	—	$	554,997
Accrued payroll		13,750		13,750
Financed director and officer insurance premiums		108,788		217,575
Accrued supplier expenses		96,744		67,971
Accrued legal settlement		—		975,000
Accrued legal and professional fees		155,530		20,323
Accrued commissions		3,681		36,109
Accrued media commissions		47,925		138,028
Credit card payable		276,724		328,075
Accrued programming expenses		—		1,750
Accrued issuable equity		708		1,258
Accrued interest		7,725		9,017
Accrued warrant exercise costs		83,519		83,519
Other		24,571		45,915
Total accrued expenses and other current liabilities	$	819,665	$	2,493,287

XML 22 R12.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2022

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY

NOTE 4 – STOCKHOLDERS’ EQUITY

Stock-Based Compensation

For the three months ended March 31, 2022 and 2021, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows:


	For the Three Months Ended
	March 31,
	2022		2021
Sales and marketing	$	35,581	$	220,508
Technology		78,875		2,863
General and administrative		317,650		17,843
Total	$	432,106	$	241,214

Common Stock

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 23 R13.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENT

3 Months Ended

Mar. 31, 2022

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT

NOTE 5 – FAIR VALUE MEASUREMENT

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:


Contingent Consideration
Beginning balance as of January 1, 2022	$	613,000
Change in fair value of contingent consideration		(589,622)
Ending balance as of March 31, 2022	$	23,378

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 24 R14.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2022

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

Settlement Agreement

XML 25 R15.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS

3 Months Ended

Mar. 31, 2022

CONCENTRATIONS

CONCENTRATIONS

NOTE 7 – CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:


	For the Three Months Ended
	March 31,
Customer	2022		2021
Customer A	42.02	%	102.40	%
Customer B	43.25	%	N/A
Total	85.27	%	102.40	%

* Less than 10%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:


	March 31,		December 31,
Customer	2022		2021
Customer A	15.98	%	22.08	%
Customer B	23.13	%	*
Customer E	19.04	%	*
Customer F	27.99	%	52.18	%
Total	86.13	%	74.26	%

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:


	For the Three Months Ended
	March 31,
Supplier	2022		2021
Supplier A	18.77	%	*
Supplier B	*		18.10	%
Supplier C	23.84	%	N/A
Supplier D	17.56	%	N/A
Supplier E	N/A		16.2	%
Supplier F	*		15.0	%
Supplier G	14.40	%	N/A
Total	74.56	%	49.30	%

* Less than 10%.

XML 26 R16.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2022

SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Net Loss Per Common Share


	For the Three Months Ended
	March 31,
	2022	2021
Warrants [1]	5,122,074	5,234,721
Restricted stock units	855,989	—
Restricted stock awards	307,791	—
Stock options	94,447	117,261
	6,380,301	5,351,982

XML 27 R17.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2022

SIGNIFICANT ACCOUNTING POLICIES

Schedule of calculation of weighted average dilutive common shares


	For the Three Months Ended
	March 31,
	2022	2021
Warrants [1]	5,122,074	5,234,721
Restricted stock units	855,989	—
Restricted stock awards	307,791	—
Stock options	94,447	117,261
	6,380,301	5,351,982

XML 28 R18.htm IDEA: XBRL DOCUMENT

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2022

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following:


	March 31,		December 31,
	2022		2021
Accrued bonuses	$	—	$	554,997
Accrued payroll		13,750		13,750
Financed director and officer insurance premiums		108,788		217,575
Accrued supplier expenses		96,744		67,971
Accrued legal settlement		—		975,000
Accrued legal and professional fees		155,530		20,323
Accrued commissions		3,681		36,109
Accrued media commissions		47,925		138,028
Credit card payable		276,724		328,075
Accrued programming expenses		—		1,750
Accrued issuable equity		708		1,258
Accrued interest		7,725		9,017
Accrued warrant exercise costs		83,519		83,519
Other		24,571		45,915
Total accrued expenses and other current liabilities	$	819,665	$	2,493,287

XML 29 R19.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2022

STOCKHOLDERS' EQUITY

Schedule of stock based compensation expense related to stock options and common stock


	For the Three Months Ended
	March 31,
	2022		2021
Sales and marketing	$	35,581	$	220,508
Technology		78,875		2,863
General and administrative		317,650		17,843
Total	$	432,106	$	241,214

XML 30 R20.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENT (Tables)

3 Months Ended

Mar. 31, 2022

FAIR VALUE MEASUREMENT

Summary of changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:


Contingent Consideration
Beginning balance as of January 1, 2022	$	613,000
Change in fair value of contingent consideration		(589,622)
Ending balance as of March 31, 2022	$	23,378

XML 31 R21.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS (Tables)

3 Months Ended

Mar. 31, 2022

CONCENTRATIONS

Summary of customer and supplier concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:


	For the Three Months Ended
	March 31,
Customer	2022		2021
Customer A	42.02	%	102.40	%
Customer B	43.25	%	N/A
Total	85.27	%	102.40	%

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:


	March 31,		December 31,
Customer	2022		2021
Customer A	15.98	%	22.08	%
Customer B	23.13	%	*
Customer E	19.04	%	*
Customer F	27.99	%	52.18	%
Total	86.13	%	74.26	%

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:


	For the Three Months Ended
	March 31,
Supplier	2022		2021
Supplier A	18.77	%	*
Supplier B	*		18.10	%
Supplier C	23.84	%	N/A
Supplier D	17.56	%	N/A
Supplier E	N/A		16.2	%
Supplier F	*		15.0	%
Supplier G	14.40	%	N/A
Total	74.56	%	49.30	%

* Less than 10%.

XML 32 R22.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Contract liabilities	$ 0	$ 395,914
Deferred revenue recognized by the company	395,914
Loss Accrual On Customer Contract	$ 789,605
Minimum
Disaggregation of Revenue [Line Items]
Invoice payment terms	45 days
Maximum
Disaggregation of Revenue [Line Items]
Invoice payment terms	90 days

XML 33 R23.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized from performance obligations satisfied	$ 0	$ 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized from performance obligations satisfaction period	12 months

XML 34 R24.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Net Loss Per Common Share
Shares excluded from the calculation of weighted average dilutive common shares	6,380,301	5,351,982
Number of warrants exercisable (in shares)	368,711		462,997
Warrants term (in years)	5 years		5 years
Warrants to purchase shares of common stock	368,711		462,997
Exercise price of warrants (in dollars per share)	$ 5.50		$ 5.50
Warrants
Net Loss Per Common Share
Shares excluded from the calculation of weighted average dilutive common shares	5,122,074	5,234,721
Restricted stock units (RSUs)
Net Loss Per Common Share
Shares excluded from the calculation of weighted average dilutive common shares	855,989
Restricted stock awards
Net Loss Per Common Share
Shares excluded from the calculation of weighted average dilutive common shares	307,791
Stock options
Net Loss Per Common Share
Shares excluded from the calculation of weighted average dilutive common shares	94,447	117,261

XML 35 R25.htm IDEA: XBRL DOCUMENT

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued bonuses		$ 554,997
Accrued payroll	$ 13,750	13,750
Financed director and officer insurance premiums	108,788	217,575
Accrued supplier expenses	96,744	67,971
Accrued legal settlement		975,000
Accrued legal and professional fees	155,530	20,323
Accrued commissions	3,681	36,109
Accrued media commissions	47,925	138,028
Credit card payable	276,724	328,075
Accrued programming expenses		1,750
Accrued issuable equity	708	1,258
Accrued interest	7,725	9,017
Accrued warrant exercise costs	83,519	83,519
Other	24,571	45,915
Total accrued expenses and other current liabilities	$ 819,665	$ 2,493,287

XML 36 R26.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY (Details) - USD ($)	3 Months Ended
STOCKHOLDERS' EQUITY (Details) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Class of Stock [Line Items]
Common stock aggregate issuance date fair value	$ 430,361	$ 513,103
Proceeds from exercise of stock options	18,000
Stock-based compensation expense	432,106	$ 241,214
Unrecognized stock-based compensation expense	$ 1,983,000
Unrecognized stock-based compensation expense, period of recognition	3 years 4 months 24 days
Issuance costs from exercise of warrants	$ 433,127
Executive Officer
Class of Stock [Line Items]
Common Stock Surrendered	3,397
2021 Equity Incentive Plan
Class of Stock [Line Items]
Common stock aggregate issuance date fair value	$ 1,900,000
2021 Equity Incentive Plan \| Restricted stock units (RSUs)
Class of Stock [Line Items]
Shares of common stock granted	489,990
2021 Equity Incentive Plan \| PSUs
Class of Stock [Line Items]
Shares of common stock granted	234,376
2021 Equity Incentive Plan \| RSAs
Class of Stock [Line Items]
Shares of common stock granted	100,000
Common stock aggregate issuance date fair value	$ 100,000
2021 Equity Incentive Plan \| Non-employees \| RSAs
Class of Stock [Line Items]
Shares of common stock granted	53,192
Minimum \| 2021 Equity Incentive Plan
Class of Stock [Line Items]
Percentage of Earning Of Grantees	0.00%
Maximum \| 2021 Equity Incentive Plan
Class of Stock [Line Items]
Percentage of Earning Of Grantees	150.00%

XML 37 R27.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 432,106	$ 241,214
Unrecognized stock-based compensation expense	$ 1,983,000
Unrecognized stock-based compensation expense, period of recognition	3 years 4 months 24 days
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 35,581	220,508
Technology
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	78,875	2,863
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 317,650	$ 17,843

XML 38 R28.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENT (Details) - Fair Value, Inputs, Level 3 [Member]	3 Months Ended
	Mar. 31, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Beginning balance as of January 1, 2022	$ 613,000
Change in fair value of contingent consideration	(589,622)
Ending balance as of March 31, 2022	$ 23,378

XML 39 R29.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENT - Additional information (Details) - USD ($)			3 Months Ended
	Mar. 31, 2022	Nov. 30, 2021	Mar. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of contingent consideration			$ 589,622
MediaCrossing Inc [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash		$ 500,000
Earnout Shares Acquired By The Company		822,369
Earnout Shares Par Value		$ 0.00001
Earnout Shares Fair Value		$ 2.55
Recomputed fair value of earnout shares	$ 26,719
Change in fair value of contingent consideration			$ 589,622

XML 40 R30.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES - Settlements (Details) - Settlement Agreements - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 31, 2022
Loss Contingencies [Line Items]
Outstanding notes payable balance		$ 975,000
Loss on legal settlement	$ 875,000

XML 41 R31.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS - Customer Concentrations (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
CONCENTRATIONS
Accounts receivable, net	$ 2,352,463		$ 2,291,533
Revenue \| Customer Concentrations \| Customer A
CONCENTRATIONS
Concentration risk (as a percent)	42.02%	102.40%
Revenue \| Customer Concentrations \| Customer B
CONCENTRATIONS
Concentration risk (as a percent)	43.25%
Revenue \| Customer Concentrations \| Top Five Customers
CONCENTRATIONS
Concentration risk (as a percent)	85.27%	102.40%
Accounts Receivable \| Customer Concentrations \| Customer A
CONCENTRATIONS
Concentration risk (as a percent)	15.98%		22.08%
Accounts Receivable \| Customer Concentrations \| Customer B
CONCENTRATIONS
Concentration risk (as a percent)	23.13%
Accounts Receivable \| Customer Concentrations \| Customer E
CONCENTRATIONS
Concentration risk (as a percent)	19.04%
Accounts Receivable \| Customer Concentrations \| Customer F
CONCENTRATIONS
Concentration risk (as a percent)	27.99%		52.18%
Accounts Receivable \| Customer Concentrations \| Top Four Customers
CONCENTRATIONS
Concentration risk (as a percent)	86.13%		74.26%

XML 42 R32.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS - Supplier Concentrations (Details) - Cost of goods sold - Supplier Concentrations	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Supplier A
CONCENTRATIONS
Concentration risk (as a percent)	18.77%
Supplier B
CONCENTRATIONS
Concentration risk (as a percent)		18.10%
Supplier C
CONCENTRATIONS
Concentration risk (as a percent)	23.84%
Supplier D
CONCENTRATIONS
Concentration risk (as a percent)	17.56%
Supplier E
CONCENTRATIONS
Concentration risk (as a percent)		16.20%
Supplier F
CONCENTRATIONS
Concentration risk (as a percent)		15.00%
Supplier G
CONCENTRATIONS
Concentration risk (as a percent)	14.40%
Top Seven Suppliers
CONCENTRATIONS
Concentration risk (as a percent)	74.56%	49.30%

XML 43 kbnt-20220331x10q_htm.xml IDEA: XBRL DOCUMENT 0001729750 kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2022-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2021-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001729750 us-gaap:RetainedEarningsMember 2021-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001729750 us-gaap:RetainedEarningsMember 2020-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001729750 us-gaap:CommonStockMember 2022-03-31 0001729750 us-gaap:CommonStockMember 2021-12-31 0001729750 us-gaap:CommonStockMember 2021-03-31 0001729750 us-gaap:CommonStockMember 2020-12-31 0001729750 kbnt:NonEmployeesMember kbnt:RestrictedStockAwardsMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:PerformanceSharesMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 kbnt:RestrictedStockAwardsMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750

2022-01-01

2022-03-31 0001729750 kbnt:SettlementAgreementsMember 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001729750 kbnt:SettlementAgreementsMember 2021-01-01 2021-12-31 0001729750 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001729750 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001729750 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierGMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierDMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierCMember 2022-01-01 2022-03-31 0001729750 kbnt:TopFourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:TopFourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2021-01-01 2021-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierFMember 2021-01-01 2021-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierEMember 2021-01-01 2021-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierBMember 2021-01-01 2021-03-31 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001729750 2021-03-31 0001729750 2020-12-31 0001729750 kbnt:MediacrossingIncMember 2021-11-30 0001729750 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0001729750 us-gaap:EmployeeStockMember 2022-01-01 2022-03-31 0001729750 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001729750 us-gaap:EmployeeStockMember 2021-01-01 2021-03-31 0001729750 us-gaap:TechnologyServiceMember 2022-01-01 2022-03-31 0001729750 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001729750 us-gaap:TechnologyServiceMember 2021-01-01 2021-03-31 0001729750 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001729750 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001729750 kbnt:MediacrossingIncMember 2022-03-31 2022-03-31 0001729750 srt:MinimumMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 srt:MaximumMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 srt:MinimumMember 2022-01-01 2022-03-31 0001729750 srt:MaximumMember 2022-01-01 2022-03-31 0001729750 kbnt:MediacrossingIncMember 2021-11-30 2021-11-30 0001729750 srt:ExecutiveOfficerMember 2022-01-01 2022-03-31 0001729750 2021-01-01 2021-12-31 0001729750 kbnt:MediacrossingIncMember 2022-01-01 2022-03-31 0001729750 2021-01-01 2021-03-31 0001729750 2022-03-31 0001729750 2021-12-31 0001729750 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001729750 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001729750 2022-05-12 0001729750 2022-01-01 2022-03-31 shares iso4217:USD iso4217:USD shares pure

0001729750 --12-31 2022 Q1

14256159

12617171

Kubient, Inc.

14303743

14253948

-0.25

-0.14

false 10-Q true 2022-03-31 false 001-39441 DE 82-1808844 500 7th Avenue, 8th Floor New York NY 10018 800 409-9456 Common Stock, par value $0.00001 per share KBNT NASDAQ Common Stock Purchase Warrants KBNTW NASDAQ Yes Yes Non-accelerated Filer true true false false 14303743

20709044

24907963

2352463

2291533

526070

411904

495178

23473411

28220744

2789625

2946610

463000

47040

44756

10000

26783076

31685110

2474570 1844544

1050395

659362

851800 2493287

26719

395914

42066

151336

4445550

5544443

23378

613000

77407

4546335

6234850

0.00001

5000000

0.00001

95000000

14303743

14253948

143

52444880

52030907

-30208282

-26580790

22236741

25450260

26783076

31685110

1245304

707757

1333010

756950

1155699

519755

2182549

1255572

789605

5460863

2532277

-4215559

-1824520

3872

1634

2291

29309

589622

233

588067

27908

-3627492

-1796612

-0.25

-0.14

14256159

12617171

14253948

143

52030907

-26580790

25450260

-3397 -18683 -18683

53192

430361

2295

-3627492

14303743

143

52444880

-30208282

22236741

11756109

118

40770504

-16289077

24481545

2047361 20 9274891 9274911

70040

513102

513103

2576

-1796612

13873510

139

50561073

-18085689

32475523

9708038

433127

-3627492

-1796612

162221

77379

589622

429811

2576

2295 238638

60930

-913623

-507387

-83274

107093

630026 -2523

391034

-378411

-1532150

-454018

1584

-369195

-3973341

-1504857

64072

7520

1882

-7520

-65954

9326163

109270

108788

-218058

9326163

-4198919

7755352

24907963

24782128

20709044

32537480

9708038 9708038 381875 -18683

500400

51252

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATIONOrganization and OperationsKubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.Risks and UncertaintiesThe novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company's operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted. Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.Basis of PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of March 31, 2022 and for the three months ended March 31, 2022 and 2021. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2021 and 2020 and for the years then ended which are included the Annual Report filed on Form 10-K on March 31, 2022.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIESThere have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2021 and 2020 and for the years then ended, which were included the Annual Report filed on Form 10-K on March 31, 2022, except as disclosed in this note.Revenue RecognitionThe Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.As of March 31, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2022, the Company recognized $395,914 of revenue that was deferred as of December 31, 2021. As of March 31, 2022 and December 31, 2021, the Company had $0 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the three months ended March 31, 2022 and 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.Net Loss Per Common ShareBasic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;">For the Three Months Ended</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;">Warrants [1]</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 5,122,074</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 5,234,721</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;">Restricted stock units</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"> 855,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;">Restricted stock awards</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 307,791</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;">Stock options</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 94,447</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 117,261</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 6,380,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 5,351,982</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div>[1] The 2022 period includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.The 2021 period includes shares underlying warrants that are exercisable into an aggregate of (i) 462,997 shares of common stock and (ii) five-year warrants to purchase 462,997 shares of common stock at an exercise price of $5.50 per share.

P45D P90D 789605

395914

P12M

Net Loss Per Common ShareBasic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;">For the Three Months Ended</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;">Warrants [1]</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 5,122,074</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 5,234,721</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;">Restricted stock units</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"> 855,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;">Restricted stock awards</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 307,791</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;">Stock options</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 94,447</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 117,261</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 6,380,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 5,351,982</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div>[1] The 2022 period includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.The 2021 period includes shares underlying warrants that are exercisable into an aggregate of (i) 462,997 shares of common stock and (ii) five-year warrants to purchase 462,997 shares of common stock at an exercise price of $5.50 per share.

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;">For the Three Months Ended</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;">Warrants [1]</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 5,122,074</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 5,234,721</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;">Restricted stock units</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"> 855,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;">Restricted stock awards</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> 307,791</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;">Stock options</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 94,447</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 117,261</td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 6,380,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 5,351,982</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div>[1] The 2022 period includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.The 2021 period includes shares underlying warrants that are exercisable into an aggregate of (i) 462,997 shares of common stock and (ii) five-year warrants to purchase 462,997 shares of common stock at an exercise price of $5.50 per share.

5122074

5234721

855989

307791

94447

117261

6380301

5351982

368711

P5Y

368711

5.50

462997

P5Y

462997

5.50

NOTE 3 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIESAccrued expenses and other current liabilities consisted of the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.82%;margin:0pt;padding:0pt;">December 31, </td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued bonuses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 554,997</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued payroll</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 13,750</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 13,750</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Financed director and officer insurance premiums</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 108,788</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 217,575</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued supplier expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 96,744</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 67,971</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued legal settlement</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 975,000</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued legal and professional fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 155,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 20,323</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 3,681</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 36,109</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued media commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 47,925</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 138,028</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Credit card payable</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 276,724</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 328,075</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued programming expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,750</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued issuable equity</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 708</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,258</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.65%;margin:0pt;padding:0pt;">Accrued interest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 7,725</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 9,017</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued warrant exercise costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 83,519</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 83,519</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 24,571</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 45,915</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Total accrued expenses and other current liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 819,665</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,493,287</td></tr></table>

Accrued expenses and other current liabilities consisted of the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.82%;margin:0pt;padding:0pt;">December 31, </td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued bonuses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 554,997</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued payroll</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 13,750</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 13,750</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Financed director and officer insurance premiums</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 108,788</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 217,575</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued supplier expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 96,744</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 67,971</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued legal settlement</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 975,000</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued legal and professional fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 155,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 20,323</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 3,681</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 36,109</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued media commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 47,925</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 138,028</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Credit card payable</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 276,724</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 328,075</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Accrued programming expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,750</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued issuable equity</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 708</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,258</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.65%;margin:0pt;padding:0pt;">Accrued interest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"> 7,725</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 9,017</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Accrued warrant exercise costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"> 83,519</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 83,519</td></tr><tr><td style="vertical-align:bottom;width:73.65%;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 24,571</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 45,915</td></tr><tr><td style="vertical-align:bottom;width:73.65%;background:#cceeff;margin:0pt;padding:0pt;">Total accrued expenses and other current liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 819,665</td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,493,287</td></tr></table>

554997

13750 13750 108788 217575 96744 67971 975000

155530

20323

3681 36109 47925 138028 276724 328075 1750 708 1258

7725

9017

83519 83519 24571 45915 819665 2493287

NOTE 4 – STOCKHOLDERS’ EQUITYStock-Based CompensationFor the three months ended March 31, 2022 and 2021, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows: <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"> </td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;margin:0pt;padding:0pt;">For the Three Months Ended</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31,</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;">Sales and marketing</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"> 35,581</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"> 220,508</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;">Technology</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"> 78,875</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"> 2,863</td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;">General and administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"> 317,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"> 17,843</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"> 432,106</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"> 241,214</td></tr></table>As of March 31, 2022, there was approximately $1,983,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 3.4 years.During the three months ended March 31, 2022, the Company granted 53,192 shares of immediately vested restricted stock awards (“RSAs”) to non-employee directors under the Kubient, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) with an aggregate grant date fair value of $100,000 that was recognized immediately.During the three months ended March 31, 2022, the Company issued 100,000 RSAs, 489,990 restricted stock units (“RSUs”) and a target number of 234,376 performance stock units (“PSUs”), all issued under the 2021 Plan. The RSAs and RSUs generally vest over four years and the PSUs are earned based upon based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,900,000.Common Stock During the three months ended March 31, 2022, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock, which were subsequently cancelled by the Company, in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"> </td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;margin:0pt;padding:0pt;">For the Three Months Ended</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31,</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;">Sales and marketing</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"> 35,581</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"> 220,508</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;">Technology</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"> 78,875</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"> 2,863</td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;">General and administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"> 317,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"> 17,843</td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"> 432,106</td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"> 241,214</td></tr></table>

35581

220508

78875

2863

317650

17843

432106

241214

1983000

P3Y4M24D

53192

100000

489990

234376

0 1.50

1900000

3397

18000

NOTE 5 – FAIR VALUE MEASUREMENTOn November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). The Earnout Shares had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.On March 31, 2022, the Company recomputed the fair value of its Earnout Shares as $26,719 using the Monte Carlo simulation. The Company recorded a gain on the change in fair value of the contingent consideration of $589,622 during the three months ended March 31, 2022.The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Contingent Consideration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">Beginning balance as of January 1, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"> 613,000</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Change in fair value of contingent consideration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (589,622)</td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">Ending balance as of March 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 23,378</td></tr></table>

500000

822369 0.00001 2.55 26719 589622

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Contingent Consideration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">Beginning balance as of January 1, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"> 613,000</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Change in fair value of contingent consideration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (589,622)</td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">Ending balance as of March 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 23,378</td></tr></table>

613000

-589622

23378

NOTE 6 – COMMITMENTS AND CONTINGENCIESFrom time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.Settlement Agreement On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”). Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment in the three months ended March 31, 2022 of $975,000 to Lo70s in consideration of the dismissal of the ligation among the parties, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the Lo70s Settlement Agreement. During the year ended December 31, 2021, the Company recognized a loss on settlement of approximately $875,000 such that, as of December 31, 2021, it had accrued for the $975,000 cash payment.

975000

875000

NOTE 7 – CONCENTRATIONSCustomer ConcentrationsThe following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;margin:0pt;padding:0pt;"> For the Three Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Customer</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;">Customer A</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 42.02</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"> 102.40</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;">Customer B</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 43.25</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 85.27</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 102.40</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div>* Less than 10%.From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;">December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:72.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Customer </td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;">Customer A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"> 15.98</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"> 22.08</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;">Customer B</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"> 23.13</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;">Customer E</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"> 19.04</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;">Customer F</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 27.99</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 52.18</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 86.13</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 74.26</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr></table>A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.Supplier ConcentrationsThe following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.33%;margin:0pt;padding:0pt;"> For the Three Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Supplier</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"> 18.77</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Supplier B</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"> 18.10</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier C</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"> 23.84</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Supplier D</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"> 17.56</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier E</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"> 16.2</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Supplier F</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"> 15.0</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier G</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"> 14.40</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 74.56</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 49.30</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div>* Less than 10%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;margin:0pt;padding:0pt;"> For the Three Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Customer</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;">Customer A</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 42.02</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"> 102.40</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;">Customer B</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 43.25</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 85.27</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 102.40</td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr></table>The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;">December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:72.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Customer </td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;">Customer A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"> 15.98</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"> 22.08</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;">Customer B</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"> 23.13</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;">Customer E</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"> 19.04</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;">Customer F</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 27.99</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 52.18</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 86.13</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 74.26</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr></table>The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.33%;margin:0pt;padding:0pt;"> For the Three Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Supplier</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"> 18.77</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Supplier B</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"> 18.10</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier C</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"> 23.84</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Supplier D</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"> 17.56</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier E</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"> 16.2</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Supplier F</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;">*</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"> 15.0</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;">Supplier G</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"> 14.40</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 74.56</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 49.30</td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;">% </td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div>* Less than 10%.

0.4202

1.0240

0.4325

0.8527

1.0240

0.1598

0.2208

0.2313

0.1904

0.2799

0.5218

0.8613

0.7426

0.1877

0.1810

0.2384

0.1756

0.162

0.150

0.1440

0.7456

0.4930

Includes gross proceeds of $9,708,038, less issuance costs of $433,127. Includes gross proceeds of $9,708,038, less issuance costs of $381,875.

EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 81 174 1 true 42 0 false 4 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.kubient.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00305 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Sheet http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Notes 9 false false R10.htm 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 10301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Notes 11 false false R12.htm 10401 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.kubient.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 12 false false R13.htm 10501 - Disclosure - FAIR VALUE MEASUREMENT Sheet http://www.kubient.com/role/DisclosureFairValueMeasurement FAIR VALUE MEASUREMENT Notes 13 false false R14.htm 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.kubient.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 10701 - Disclosure - CONCENTRATIONS Sheet http://www.kubient.com/role/DisclosureConcentrations CONCENTRATIONS Notes 15 false false R16.htm 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.kubient.com/role/DisclosureSignificantAccountingPolicies 17 false false R18.htm 30303 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Tables http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 18 false false R19.htm 30403 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.kubient.com/role/DisclosureStockholdersEquity 19 false false R20.htm 30503 - Disclosure - FAIR VALUE MEASUREMENT (Tables) Sheet http://www.kubient.com/role/DisclosureFairValueMeasurementTables FAIR VALUE MEASUREMENT (Tables) Tables http://www.kubient.com/role/DisclosureFairValueMeasurement 20 false false R21.htm 30703 - Disclosure - CONCENTRATIONS (Tables) Sheet http://www.kubient.com/role/DisclosureConcentrationsTables CONCENTRATIONS (Tables) Tables http://www.kubient.com/role/DisclosureConcentrations 21 false false R22.htm 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Details 22 false false R23.htm 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) Details 23 false false R24.htm 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Details 24 false false R25.htm 40301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Details http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 25 false false R26.htm 40401 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://www.kubient.com/role/DisclosureStockholdersEquityTables 26 false false R27.htm 40402 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Details 27 false false R28.htm 40501 - Disclosure - FAIR VALUE MEASUREMENT (Details) Sheet http://www.kubient.com/role/DisclosureFairValueMeasurementDetails FAIR VALUE MEASUREMENT (Details) Details http://www.kubient.com/role/DisclosureFairValueMeasurementTables 28 false false R29.htm 40502 - Disclosure - FAIR VALUE MEASUREMENT - Additional information (Details) Sheet http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails FAIR VALUE MEASUREMENT - Additional information (Details) Details 29 false false R30.htm 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES - Settlements (Details) Sheet http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails COMMITMENTS AND CONTINGENCIES - Settlements (Details) Details 30 false false R31.htm 40701 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails CONCENTRATIONS - Customer Concentrations (Details) Details 31 false false R32.htm 40702 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails CONCENTRATIONS - Supplier Concentrations (Details) Details 32 false false All Reports Book All Reports kbnt-20220331x10q.htm kbnt-20220331.xsd kbnt-20220331_cal.xml kbnt-20220331_def.xml kbnt-20220331_lab.xml kbnt-20220331_pre.xml kbnt-20220331xex31d1.htm kbnt-20220331xex31d2.htm kbnt-20220331xex32d1.htm kbnt-20220331x10q001.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 50 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kbnt-20220331x10q.htm": { "axisCustom": 0, "axisStandard": 15, "contextCount": 81, "dts": { "calculationLink": { "local": [ "kbnt-20220331_cal.xml" ] }, "definitionLink": { "local": [ "kbnt-20220331_def.xml" ] }, "inline": { "local": [ "kbnt-20220331x10q.htm" ] }, "labelLink": { "local": [ "kbnt-20220331_lab.xml" ] }, "presentationLink": { "local": [ "kbnt-20220331_pre.xml" ] }, "schema": { "local": [ "kbnt-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 291, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 12, "http://xbrl.sec.gov/dei/2021q4": 6, "total": 18 }, "keyCustom": 37, "keyStandard": 137, "memberCustom": 19, "memberStandard": 21, "nsprefix": "kbnt", "nsuri": "http://www.kubient.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - STOCKHOLDERS' EQUITY", "role": "http://www.kubient.com/role/DisclosureStockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - FAIR VALUE MEASUREMENT", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurement", "shortName": "FAIR VALUE MEASUREMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.kubient.com/role/DisclosureCommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - CONCENTRATIONS", "role": "http://www.kubient.com/role/DisclosureConcentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - FAIR VALUE MEASUREMENT (Tables)", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurementTables", "shortName": "FAIR VALUE MEASUREMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30703 - Disclosure - CONCENTRATIONS (Tables)", "role": "http://www.kubient.com/role/DisclosureConcentrationsTables", "shortName": "CONCENTRATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EnergyMarketingContractLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EnergyMarketingContractLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueRemainingPerformanceObligation", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueRemainingPerformanceObligation", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0fTcRNKg-kekfe6gMYuDuA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0fTcRNKg-kekfe6gMYuDuA", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_12_31_2021_la04XLv4J0-BXSb8R6Tw_w", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_12_31_2021_la04XLv4J0-BXSb8R6Tw_w", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "reportCount": 1, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "shortName": "STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_rYKmmznHnUq8OeIaCoz2BQ", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_mWLZ7Ho2MkOcXx8GvezTVQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - FAIR VALUE MEASUREMENT (Details)", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails", "shortName": "FAIR VALUE MEASUREMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_mWLZ7Ho2MkOcXx8GvezTVQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "kbnt:ChangeInFairValueOfContingentConsideration", "reportCount": 1, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - FAIR VALUE MEASUREMENT - Additional information (Details)", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "shortName": "FAIR VALUE MEASUREMENT - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_11_30_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_ZKe3N2Ax6kS7a5s_bOLhyw", "decimals": "0", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_Eaup7kARCk6bF3lMqP0zIg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_Eaup7kARCk6bF3lMqP0zIg", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_LossContingenciesByNatureOfContingencyAxis_kbnt_SettlementAgreementsMember_Jf2p8iPZ-kyXnGcQcOJhAw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayable", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - COMMITMENTS AND CONTINGENCIES - Settlements (Details)", "role": "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Settlements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_LossContingenciesByNatureOfContingencyAxis_kbnt_SettlementAgreementsMember_Jf2p8iPZ-kyXnGcQcOJhAw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayable", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_frDR615sSEKL9UKwQSJedA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details)", "role": "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "shortName": "CONCENTRATIONS - Customer Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_srt_MajorCustomersAxis_kbnt_CustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_ROZYZSeCj0GCJdOhIFvzoQ", "decimals": "4", "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure__LjTITQVHUCbTBJ_98gk_A", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierMember_oNvS_D7Uj0abyEpsE3clOw", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure__LjTITQVHUCbTBJ_98gk_A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40702 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details)", "role": "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails", "shortName": "CONCENTRATIONS - Supplier Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierMember_oNvS_D7Uj0abyEpsE3clOw", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure__LjTITQVHUCbTBJ_98gk_A", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_X5dOhk2o6U2-snCh4U5ljw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_X5dOhk2o6U2-snCh4U5ljw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_Q2UibTeUtECkPqfCJes1zg", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION", "role": "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation", "shortName": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_slpMGH9WwEKAz6obmSUwMw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 42, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Adress Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kbnt_AccountsPayableSupplierCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable to supplier for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Supplier, Current", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "AccountsPayableSupplierCurrent", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccrualOfIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accrual of issuance costs.", "label": "Accrual Of Issuance Costs", "terseLabel": "Accrual of issuance costs" } } }, "localname": "AccrualOfIssuanceCosts", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other other than interest payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued And Other Liabilities, Current, Other Than Interest Payable", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 9.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued commissions.", "label": "Accrued Commissions", "terseLabel": "Accrued commissions" } } }, "localname": "AccruedCommissions", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities", "totalLabel": "Total accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilitiesOthers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities, Others", "terseLabel": "Other" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesOthers", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedIssuableEquity": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued issuable equity.", "label": "Accrued Issuable Equity", "terseLabel": "Accrued issuable equity" } } }, "localname": "AccruedIssuableEquity", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedLegalSettlement": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued legal settlement.", "label": "Accrued Legal Settlement", "terseLabel": "Accrued legal settlement" } } }, "localname": "AccruedLegalSettlement", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedMediaCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 10.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued media commissions.", "label": "Accrued Media Commissions", "terseLabel": "Accrued media commissions" } } }, "localname": "AccruedMediaCommissions", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedPayroll": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll", "terseLabel": "Accrued payroll" } } }, "localname": "AccruedPayroll", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedProgrammingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued programming expenses payable.", "label": "Accrued Programming Expenses", "terseLabel": "Accrued programming expenses" } } }, "localname": "AccruedProgrammingExpenses", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedSupplierExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 12.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued supplier expenses.", "label": "Accrued Supplier Expenses", "terseLabel": "Accrued supplier expenses" } } }, "localname": "AccruedSupplierExpenses", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedWarrantExerciseIssuanceCostsCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for warrant exercise issuance costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Warrant Exercise Issuance Costs, Current", "terseLabel": "Accrued warrant exercise costs" } } }, "localname": "AccruedWarrantExerciseIssuanceCostsCurrent", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_ChangeInFairValueOfContingentConsideration": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of change in fair value of contingent consideration.", "label": "Change In Fair Value Of Contingent Consideration", "negatedLabel": "Change in fair value of contingent consideration", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "ChangeInFairValueOfContingentConsideration", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_ClassOfWarrantOrRightNumberOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercisable in to shares of common stock.", "label": "Class of Warrant or Right, Number of Warrants Exercisable", "terseLabel": "Number of warrants exercisable (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsExercisable", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Right", "terseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_CommonStockSurrendered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares surrendered.", "label": "Common Stock Surrendered" } } }, "localname": "CommonStockSurrendered", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_CreditCardPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of credit card payable.", "label": "Credit Card Payable", "terseLabel": "Credit card payable" } } }, "localname": "CreditCardPayable", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer B.", "label": "Customer B" } } }, "localname": "CustomerBMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer E.", "label": "Customer E" } } }, "localname": "CustomerEMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer F.", "label": "Customer F" } } }, "localname": "CustomerFMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer A.", "label": "Customer A" } } }, "localname": "CustomerMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_EarnoutSharesAcquiredByCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of earnout shares acquired by the company.", "label": "Earnout Shares Acquired By The Company" } } }, "localname": "EarnoutSharesAcquiredByCompany", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "kbnt_EarnoutSharesFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of the earn out shares.", "label": "Earnout Shares Fair Value" } } }, "localname": "EarnoutSharesFairValue", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "kbnt_EarnoutSharesParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Par value of the earn out shares.", "label": "Earnout Shares Par Value" } } }, "localname": "EarnoutSharesParValue", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "kbnt_FinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 14.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of financed director and officer insurance premiums, current.", "label": "Financed Director And Officer Insurance Premiums", "terseLabel": "Financed director and officer insurance premiums" } } }, "localname": "FinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow from issuance of convertible notes payable and investor warrants.", "label": "Gross Proceeds From Convertible Notes Payable and Investor Warrants", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow associated with the amount received from entity's first offering of stock to the public, before deduction of offering costs.", "label": "Gross Proceeds from Issuance Initial Public Offering", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "GrossProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_IncreaseDecreaseInAccountsPayableSuppliers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of supplies used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Suppliers", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "IncreaseDecreaseInAccountsPayableSuppliers", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_InvoicePaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Invoice payment terms.", "label": "Invoice Payment Terms", "terseLabel": "Invoice payment terms" } } }, "localname": "InvoicePaymentTerms", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "durationItemType" }, "kbnt_LossAccrualOnCustomerContract": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents loss accrual on customer contract.", "label": "Loss Accrual On Customer Contract" } } }, "localname": "LossAccrualOnCustomerContract", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_MediacrossingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for MediaCrossing Inc.", "label": "MediaCrossing Inc [Member]" } } }, "localname": "MediacrossingIncMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kbnt_NonEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to non employees.", "label": "Non-employees" } } }, "localname": "NonEmployeesMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from payments of offering costs for issuance of convertible notes payable and investor warrants.", "label": "Payments Of Offering Costs for Issuance of Convertible Notes Payable and Investor Warrants", "verboseLabel": "Payments of offering costs for initial public offering" } } }, "localname": "PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_PercentageOfEarningOfGrantees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of grantees earnings.", "label": "Percentage of Earning Of Grantees" } } }, "localname": "PercentageOfEarningOfGrantees", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "kbnt_RecomputedFairValueOfEarnoutShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Recomputed fair value of earnout shares.", "label": "Recomputed fair value of earnout shares" } } }, "localname": "RecomputedFairValueOfEarnoutShares", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_RepaymentOfFinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt.", "label": "Repayment Of Financed Director And Officer Insurance Premiums", "negatedLabel": "Repayment of financed director and officer insurance premiums" } } }, "localname": "RepaymentOfFinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_RestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock awards member.", "label": "RSAs" } } }, "localname": "RestrictedStockAwardsMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the accrued expenses and other current liabilities .", "label": "Schedule Accrued Expenses And Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "localname": "ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "kbnt_ServiceProvidersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to service providers for employees and non-employee.", "label": "Service Providers" } } }, "localname": "ServiceProvidersMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_SettlementAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for settlement agreements.", "label": "Settlement Agreements" } } }, "localname": "SettlementAgreementsMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SharesIssuedAndForfeitedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued and forfeited during the period.", "label": "Shares Issued and Forfeited During The Period Shares", "terseLabel": "Surrender and cancellation of common stock (in shares)" } } }, "localname": "SharesIssuedAndForfeitedDuringPeriodShares", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kbnt_SharesIssuedAndForfeitedDuringPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of shares issued and forfeited during the period.", "label": "Shares Issued and Forfeited During The Period Value", "terseLabel": "Surrender and cancellation of common stock" } } }, "localname": "SharesIssuedAndForfeitedDuringPeriodValue", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kbnt_SharesIssuedSharesUponExerciseOfWarrantsNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued upon exercise of warrants, net of issuance costs .", "label": "Shares Issued Shares Upon Exercise Of Warrants Net Of Issuance Costs", "terseLabel": "Shares issued upon exercise of warrants, net of issuance costs (in shares)" } } }, "localname": "SharesIssuedSharesUponExerciseOfWarrantsNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kbnt_SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of value of shares issued upon exercise of warrants, net of issuance costs.", "label": "Shares Issued Value Upon Exercise Of Warrants Net Of Issuance Costs", "terseLabel": "Shares issued upon exercise of warrants, net of issuance costs" } } }, "localname": "SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kbnt_StockOptionsPlanExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of stock options plan expense.", "label": "Stock Options Plan Expense", "verboseLabel": "Stock-based compensation: Options" } } }, "localname": "StockOptionsPlanExpense", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SupplierBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier B.", "label": "Supplier B" } } }, "localname": "SupplierBMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier C.", "label": "Supplier C" } } }, "localname": "SupplierCMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier D.", "label": "Supplier D" } } }, "localname": "SupplierDMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier E.", "label": "Supplier E" } } }, "localname": "SupplierEMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier F.", "label": "Supplier F" } } }, "localname": "SupplierFMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "his member stands for Supplier G.", "label": "Supplier G" } } }, "localname": "SupplierGMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier A.", "label": "Supplier A" } } }, "localname": "SupplierMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFiveCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Five Customers.", "label": "Top Five Customers" } } }, "localname": "TopFiveCustomersMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFourCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Four Customers.", "label": "Top Four Customers" } } }, "localname": "TopFourCustomersMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopSevenSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Top Seven Suppliers.", "label": "Top Seven Suppliers" } } }, "localname": "TopSevenSuppliersMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty One Equity Incentive Plan member.", "label": "2021 Equity Incentive Plan" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://www.kubient.com/20220331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "label": "Executive Officer" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r122", "r196", "r199", "r309" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r161", "r170", "r214", "r216", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r308", "r310", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r161", "r170", "r214", "r216", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r308", "r310", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r122", "r196", "r199", "r309" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r161", "r170", "r204", "r214", "r216", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r308", "r310", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r161", "r170", "r204", "r214", "r216", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r308", "r310", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r123", "r273" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.", "label": "Accounts and Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "AccountsAndOtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r8", "r26" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable - trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r16", "r124", "r125" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r7", "r8", "r29" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 13.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Bonuses, Current", "terseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r7", "r8", "r29" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 11.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued legal and professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r17", "r231", "r276" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r70", "r71", "r72", "r228", "r229", "r230", "r249" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Stock-based compensation: Options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r218", "r224", "r232" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense", "totalLabel": "Total" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from the calculation of weighted average dilutive common shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r68", "r109", "r112", "r118", "r127", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r240", "r244", "r263", "r274", "r276", "r290", "r300" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets.", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r35", "r68", "r127", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r240", "r244", "r263", "r274", "r276" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r220", "r226" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r213", "r215" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r213", "r215", "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r237", "r238" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r25", "r276", "r317", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r25", "r58" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r53", "r58", "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and Cash Equivalents - End of the Period", "periodStartLabel": "Cash and Cash Equivalents - Beginning of the Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r53", "r264" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (Decrease) Increase In Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "verboseLabel": "Exercise price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r32", "r139", "r293", "r305" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 5)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r136", "r137", "r138", "r146", "r320" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r70", "r71", "r249" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r184" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r276" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,303,743 and 14,253,948 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommunicationsAndInformationTechnology": { "auth_ref": [ "r46" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense in the period for communications and data processing expense.", "label": "Communications and Information Technology", "terseLabel": "Technology" } } }, "localname": "CommunicationsAndInformationTechnology", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r101", "r102", "r122", "r260", "r261", "r319" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r101", "r102", "r122", "r260", "r261", "r316", "r319" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r101", "r102", "r122", "r260", "r261", "r316", "r319" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "CONCENTRATIONS.", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r101", "r102", "r122", "r260", "r261" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r99", "r101", "r102", "r103", "r260", "r262", "r319" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r101", "r102", "r122", "r260", "r261", "r319" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r100", "r122" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentrations" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCosts": { "auth_ref": [ "r12", "r289", "r299" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.", "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeCurrent": { "auth_ref": [ "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Income, Current", "terseLabel": "Deferred revenue recognized by the company" } } }, "localname": "DeferredIncomeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r56", "r108" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r43", "r75", "r76", "r77", "r78", "r79", "r83", "r86", "r89", "r90", "r91", "r94", "r95", "r250", "r251", "r295", "r307" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss Per Share - Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r43", "r75", "r76", "r77", "r78", "r79", "r86", "r89", "r90", "r91", "r94", "r95", "r250", "r251", "r295", "r307" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net Loss Per Share - Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r92", "r93" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r225" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense", "verboseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized stock-based compensation expense, period of recognition", "verboseLabel": "Unrecognized stock-based compensation expense, period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Stock options" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EnergyMarketingContractLiabilitiesCurrent": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities attributable to energy marketing activities (trading activities). Current energy marketing (trading activities) are when entities engage in both financial and physical trading to increase profits, manage their commodity price risk and enhance system reliability. They may trade electricity, coal, natural gas and oil. These entities typically use a variety of financial instruments, including forward contracts, options and swaps.", "label": "Energy Marketing Contract Liabilities, Current", "terseLabel": "Contract liabilities" } } }, "localname": "EnergyMarketingContractLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r38", "r39", "r40", "r70", "r71", "r72", "r74", "r80", "r82", "r96", "r128", "r184", "r191", "r228", "r229", "r230", "r233", "r234", "r249", "r265", "r266", "r267", "r268", "r269", "r270", "r311", "r312", "r313", "r330" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r252", "r253", "r254", "r259" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r162", "r163", "r164", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r253", "r277", "r278", "r279" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENT" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENT" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurement" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r162", "r163", "r164", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r253", "r279" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r256" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance as of March 31, 2022", "periodStartLabel": "Beginning balance as of January 1, 2022" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r162", "r163", "r164", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r277", "r278", "r279" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r139" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "negatedLabel": "Loss on legal settlement", "verboseLabel": "Loss on legal settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r129", "r130", "r276", "r288" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r134", "r135" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "negatedLabel": "Other receivable" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable - trade" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Accrued interest" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r131", "r132" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r41", "r107", "r271", "r272", "r296" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "verboseLabel": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r8", "r9", "r29" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r28", "r68", "r113", "r127", "r150", "r151", "r152", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r241", "r244", "r245", "r263", "r274", "r275" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r68", "r127", "r263", "r276", "r292", "r303" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Deficiency", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r30", "r68", "r127", "r150", "r151", "r152", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r241", "r244", "r245", "r263", "r274", "r275", "r276" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r31" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes Payable, Noncurrent", "terseLabel": "Notes payable, non-current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r53" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash (Used In) Provided By Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r53" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used In Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r53", "r54", "r57" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used In Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r36", "r37", "r40", "r42", "r57", "r68", "r73", "r75", "r76", "r77", "r78", "r81", "r82", "r87", "r109", "r111", "r114", "r117", "r119", "r127", "r150", "r151", "r152", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r251", "r263", "r294", "r306" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r75", "r76", "r77", "r78", "r83", "r84", "r88", "r91", "r109", "r111", "r114", "r117", "r119" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net Loss Attributable to Common Shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r47" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (Expense) Income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r13", "r291", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable", "terseLabel": "Outstanding notes payable balance" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Costs and Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Costs and Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r109", "r111", "r114", "r117", "r119" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss From Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r45" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "terseLabel": "Issuance costs from exercise of warrants", "verboseLabel": "Issuance costs on initial public offering" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r48" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r48" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "PSUs" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r14", "r168" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r14", "r168" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14", "r276" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r23", "r24" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r49", "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "verboseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r49" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "verboseLabel": "Proceeds from exercise of warrants [1]" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r36", "r37", "r40", "r52", "r68", "r73", "r81", "r82", "r109", "r111", "r114", "r117", "r119", "r127", "r150", "r151", "r152", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r239", "r242", "r243", "r246", "r247", "r251", "r263", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r133", "r276", "r298", "r304" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r50" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of PPP loan" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Stock-based compensation: Common stock" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted stock awards" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted stock units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r191", "r231", "r276", "r302", "r314", "r315" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r70", "r71", "r72", "r74", "r80", "r82", "r128", "r228", "r229", "r230", "r233", "r234", "r249", "r311", "r313" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r105", "r106", "r110", "r115", "r116", "r120", "r121", "r122", "r195", "r196", "r287" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net Revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r101", "r122" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue recognized from performance obligations satisfied" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue recognized from performance obligations satisfaction period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of calculation of weighted average dilutive common shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r218", "r223", "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r218", "r223", "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of stock based compensation expense related to stock options and common stock" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r33", "r66", "r97", "r98", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r173", "r177", "r182", "r185", "r186", "r187", "r188", "r189", "r190", "r191" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r99", "r101", "r102", "r103", "r260", "r262" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Summary of customer and supplier concentrations" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares of common stock granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r217", "r221" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r63", "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r34", "r38", "r39", "r40", "r70", "r71", "r72", "r74", "r80", "r82", "r96", "r128", "r184", "r191", "r228", "r229", "r230", "r233", "r234", "r249", "r265", "r266", "r267", "r268", "r269", "r270", "r311", "r312", "r313", "r330" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Changes in Stockholders' Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r70", "r71", "r72", "r96", "r287" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r59", "r60", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Shares of common stock issued in satisfaction of accrued issuable equity" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r184", "r191" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock (in shares)", "verboseLabel": "Number of shares issued under share based compensation plan" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r191", "r219", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock", "verboseLabel": "Common stock aggregate issuance date fair value" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r19", "r20", "r68", "r126", "r127", "r263", "r276" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficiency:", "terseLabel": "Stockholders' Equity :" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r67", "r169", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r183", "r191", "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Disclosures of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentrations" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TechnologyServiceMember": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design.", "label": "Technology Service [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyServiceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Warrants term (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r85", "r91" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Common Shares Outstanding - Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r83", "r91" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Common Shares Outstanding - Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r323": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r324": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r325": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r326": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r327": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r328": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r329": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" } }, "version": "2.1" } ZIP 51 0001410578-22-001653-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-22-001653-xbrl.zip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

WT"T \J &D5TI":9\3\!NI8%*\;PO4(A FW)G)#8IIBDI[G.K5[T?^V3?70S+#TN?I[UG?]3=?O;Y)5=611)'-NJRK!3LMCW1?-E?+ M;&7CM2Y)>0+!R98UCM^VVX7$I2_SBU.^C-7>4/$. F?\WFOF?;=7%$II&MP: MY84F5*<7OLY?"F=R[90\\0*_C.=L8JIDG-%P:(QK=T;%T=RLW.E?^#J? L\' M7F[ZL'!>N.F4WYV7ZR+G.N.V)G$MJGFV:MMYPODHN_-AT>P,XAFAR#RI^BBD;M3*;3V3+\WJG>^E:V"GP?.#E_JAMM>%(7:WPA,=K MZK0KUL76+=&NL K;H?E+MZ=VIOG-;:C=99V-BW<#-IM3A7D7=)NE&F,EK$L7 MT%^UK&>B2N^N:MINQF^Y>;$I!HN@AY.FA,^:$5@O2Z7:7=8NJ]8&!N5P(H5[ M=GK B*PYO/1=]JN6]6 [ZVOQ'M>7VBC#LJ85;!4%Q@+9?(QB5!U;L$:F,P=@ MK20_J%A3V57;\Q%X;!W&!73%7\6HPQ9/?W:PD,E\.&N;O6*K092&_LR*!U-\ M@)^=U(#TO=E+WU6X9)? SS+4FUEY:V56SWEA:3[_P"@>](D8XC:.MF#RN%XH M;NTU6^*QP*0*LU9=+TX%**M[-"&HV88^/UM_Y1,&WV+#YV@6 MUOFRU+PJ0\$ ;;/'C^>/C-L"/C3$+]92O*A1(UZOW^/&O&OGE(92 M*PZ29ZM/O'WB*\'X_,S/W>7\QDW[4V'"6VI\)Q0(42?--[)7'[(+Q!TO$&^G3?(H_+&GLC5 M ?<0EN@72YEF1A;QVQ&!"_U.T^7/UN=RIGO(QQEGR[]^>$TZ*^MN>$@K-7]X MF8VA3L4>![80-ZQ2@UHG^7G;4'28,+'.E^D'&L>>)L M]YNW3?Q1N+PP\W-7-IZ-;Q]P\:U.^3Z>=ZB*45.Z,SXW 8OV[=F:]^>_^ >+ M@K]1TSP@*\P6\K!<--,+HS,MU^^<2;UE3LY6MSA35C@[+?09OH&;*G)!+=LV M=<](S5-PAQU8LFL\";Q[?DW+.8[JU5U'#12_#'6U)][&/;WM..-;P0A2%[@[ M;9_T%?J>PV)?X4.3MEJ%2N,JB+DJN^6U40&AI0,A-5_WO.'B=$8MY)A8?[/6 MB;*96JGEXO<6 :B,6YP4^D-I?+8L_MH:;:8-/+](G_=QOK"ZCT-X97D_/XK/ M\<7:);N?,2()\-TDP/J3=8I]==*2,G%Q2,B]N3#R!%HQ:Q'P?P[PM_DAPOMW MQ7MNU3>8QR=@JJ:Z(E?.*$F@CRNR?;;>CPCP1P-\+D+\]T9\9M7WH*UF1LJ\ MT"4"+3WJ"]5I3QI'B/]YB,]$B/_>B$^O^F;L?BZ1"*2X4*JIYFA!CT=$/E+J M?Q[BTS\/\>A@144>.FXZ\'S' JZWY?W*.L'C-Z_#>K^02"J*$]B^UP0*T"=R MS_R(@%B/XCD!H8QK 9$2J@TC=]<0,CE&28O:V46?T#F+77(_.I7VT/LH2'U& M8CRW4E\D+5Y9XPB7C[C4)^#3N%SEW&5=QT*Q<525KZ/[@W6_1P#I8-%2^,&X M41/T7$ZAAWP]Q3?/;J=]%:2[Q/]*D+YIV2+$GA-BWPZIFVEX3#[%D#,>=0Q;Q8F=P1.@H,S"MQ4!Y=EK'YA- 1$B,D[D>B<-9( M;-\QV;$]4>K&O+B8I+/Q=&7!7.:6*$1(C)#X$A)3EV,^#FY5)YY?V!4Q,(9\ M<7@;I)3X9<(R%=F/$4:/C]$OV2UE45@0%2>%"U;<2H'^?!*X9@3+:+<\=R0^ M/>?X;<*6G9R%]YJW]RFQ=JO&\QFJSX/492$R"EN>")BG.$?Z&6!>A(^U1QD9 MUPZR$V+,XFFUH+'=Z>UE 3+RL49 _ 9.UC8Y5#JDFLB*7'*)GITE'R#]Z6OUKVD^$^ M'_#I$ M3,=[$SE;'+LBER@.[^UZB1R"L]/8(\0?'?&OA;(CQ%\XXM=AKDRB,Z&F2D40 M<_.V2@_]W%TMB!#_\Q#_6CCN&R+^>Q[1D;-*WAF(E;&(^\5X-S\4[O#SJPP; M'='Y7IZXTR/V\H[HF.K =LM>#3?P66^8J0VYA7MW=IZU,XU410@]#4*?7LJ9 M9X8C*SUOZT*MHE7SV42[S]\?78%\ Z6^Y.[*R4!OU2G38<5QF\U;]Z!2UXY_ M_^_[9G_HN[))B2:V3:94X$'EVO.2RCC0O?!VZ$>Y7 &J+BNNX\$V_8*MK(3? M?0G052HYXXQ67&8]J5EZF: ;BEJ 25PX>R!)\P4,U"!NI2_UBCPP[YJVKIV?QVX2_MDOK^#K9VR M([O03%D12)K-!U:%(\RNT2+\S&!$W^?9R=G:I$>DS^,.LT6@;YTH>$(N?/DN M3-^:DR:>SQ:(UB"?SE#)R?U=<+9EQ;Z$*S]V$6;$I8?DTA5WIO):J3]A/5P8 M#T>ID3V?%NOGEQA^2NZ,N/*87+F^7'J3)W4@I\&LY%'$O'V7!CIS3^KUGRTQ M]Y#I6W/D,S&6K]IOBJ\;*>2SXV7OU5\K%<^#(9W;J@JTX%GBX+:_L*/*#,V7=I@V4 M@>V83G^^"O&MN*HZ-?1RELGUB7E6DG/,/,^S_-ERU0LS?>2*9Z;ZK7?,3W!& M"Y@FA%[25BNR:P!T5YXP&T'*KUG$O2M9UL+.V^*8KX&"G'865.IL-\$WL9TH<_L/7D!-S4G57"%\7TB*17FN#"OG*VE=Y9[SSEH)9_@ MC%?WGJ <]"UE)'=%/1$?C?%NMX2:BW"FF2$ M5N4VH^23EZVLG';O.6.N>=M5Z$E5#2.OLEF7=;5@I^61[LOFBE\JDSNM2)'\ MG1'DB?Y U-I*NW&V>] ;;T1_<R!T[T_S6'/&,M7,(V=$A74<>I^Z'8J<[)NH]:VCG$V?K.SEK MV7%2"^>1._:RRD?RE$K]5,&Y961-T&<%P>6[>2&EGRUKG#I/Z2DK;*[O.;A( M4 )Q4[;[RT3=,)T8ZF%68#U)[PUCQX'B!RZD5-V4-_BD/77: R?P9%MM3R$M MYC4;+(%8"+,_H3Z'?K#>=X:%;LWH$S.!THI<=SZ\)TGQ[,P>E./[0):KWV'* M[R9=GF61-S/F7H*NT_W?0]'O*;C>S*WR[)C<>LMV1S72-G#1*CKU-N/7I\/J M17#K)ETB;CT7;MV2K;3WN6F-\[M27^]\_MFPJ"_>4%)X/;!E<"@2*T M+'N0I8RI0 I'A_)1_4Y'J@9W0&="NT\U[HUL M#88>?=+3^T&_,M0JG*"[D_1P=#M))]7+AM!1#HE2DN9FFAS)>BVA5$Z(I6FC M503JF1T2I8YT2)243)E@NN4)4R3P5+?5XYM<>RJ= Y]LGRH\S"'1@WKMMW.X MG0&?KC=KM;RH9YE,D1LRT_;YUJ-[HY?^QY_L^VA$+V'6R+YWIY;%VBV17 Q- M>9+LG.U>>G81O5-PQ%(RLD@VABS0FBQ*C32U: IS&TCM>B=H$H,S.ST/)\]" MV7ATP>B9HTHNG^A,A5)RP3D]JR5.*^>P29R$:P);7U(-G2E%(L)695>5/'2B MP),(K:TTJZ4^;@!# UR_OOUN_1@UYYJ-C* M2 U*U'MM(/I"VJB/M701>.2BO_-$W7,8BHS?P)^\_X$99*:"\'&K>0IR,(H; MR6;:X'I9VJR,Z\2B\/C4T*X%FYU5 PM +G/<#PYLY_?HPPRP'4NW]W7[5@IO M=?%K>_1O7X@1[%:2RL-VH=VXS8OI7CM5E!)\WY">6WOTBY<70I_=N, ,@>D- M]!$FN]"D,;?QA-I?.V[_%T40]*]5BU^:K/BXYCB^[?C@"M-^I MD@)Z<H!-M+D%>8XZK _>>*A#/\]62PQQH]1UH]:=8R$X)EN^U!2\S:%1&- MGF0N8?ASYY[Q62+E&^/;2L=EJ;QWWT7#YR]A] ZI&[>3VY1*E+A$*9T=%/I> MH0]'SU["Z/OWM:2FS=*BD1Z,F+Y"W"ZR>A+YGKF-X<>)'M$#("'!P;(2H_1X MB:?CE)10$AK'$Z1&RNPKPU]^XCF!JP!O^78 9#7\WSCQ^Y>G_P\)FS='FL'CP!?UT]Z=7M MZS;N.Z,;BKSF1OY?&\^ 34?KAAKH$>(&,#%VC_7/VK74O#M]Y( MMK<>&;Z^L1W7DLUEMU,0SF_UT=7O-KI5 G,T#%700LKHW[]0+Y"$,OS?: \I M%1/([DW/\0=_/:7J#KF@P,<'RR?2]#7!+$=]&+*L%PR.Q'>L&W+C([0@Z#U2 M)W#9U/OV#0K+ O>O7LA1#[^Y1K3T'%-7L7\1X7_K%J@+>L_7CXOQUUZ"A\.# M7VX2N^>8ZNJ'#T^F8)N)[ND]W81JU\U 5Z%*!KO\WW_Q%$'_]; *HT.1:Y<6 M;YD*>]BIR.&6+O5D7@.\JDA*7"$DAF%4B5L5,R6D0VJ OTFXR@! M\DB@*HE7(>*KLNM*A:)1HZQX8!"67,B+3'XHE>O35P9,$GACN?); _[QG!#? M50RH1[W@)8K^@4XJ834;_'E@1&U3;9N_-*1O^/]< MV=5QV*\1R"Y<37/>!"/']3WZ';FA MT'< M)A:PUMR"1-R<>&*_!/O??R7B#/?77L;=8:=G'X/Z(3GB@7&B7WZO7^[9$I_A MIX:8;+:%9OD.:PKU6K.-U<5F2TQ6VUB[AL&MOKW>S[]B,"2-U9H8R?ZA_OEE MSZQEL79>P#:TF@>-)IEN8_!K,D$S1Q5H9[D-?%3U>H;,6ST:M M,;\S+)*HS<=L?U>LOT0 #&Z.RF#)I309P]#((O5C=^2)5P;^'H6DUOQ"U?[I MP,Z2NF>I3H6WB(3^G1U]2LQT6KE14JF+N8$3! MM.HKC!]>GF$B?BGYY&'6B MW4Q66P6D-44*5:10O6=C>]7!LM*@_ =IN5:A4)!DO5J]ESH)'Z\"Q5D*;EQQ M3,>]63N@GWYKZC:X":!ZYJ)7.U\O(P"A#_N!6[[R[RMSW1Z2[T0$>H9 D??S MX,8.2K32/92CA65U$V!0H^@!]V:#WD?TD0IAN@UZ[O*Q&]H4U^^/7%XW?4.O MD[2BFM)"W^.=>FEJ!$'B=()AR,AV^9B(UZT^YKG*/ULCER9"WA^@Q?CNHF M'_XC-:IQ(3 6%F/(MW*ZT@%,N8Q/=Z7)1T?X(M5V'5"Q1J M[+\WUW'UN/6:_O+5MW9%7B?X W7%Q*]9\M6^?OGN8:;_)#EE-'L^]^3).+YF M"WC9!^6A]/:1ZTR0>#BX[W>I+Z$2>^YHI;J'^?1I)[!]=YYVU)4G&.+(['!, MI9_ 74.O^(9[J^=N6[=)^&#B74I4!F[ 4QEECSZC0[V;*9];X-!8'"&/N7_, M17Z#^-]GG[QOIBO,7!8O'X%5V_*LL,JR7]:!W-3S(9/*9CM/\S6[(73B?2+E M:XUZ?=I'CWP7D_(43O($SS/,RVSZ,2$%5<]]$FJ97_>%2_K9M)<_0EF!.2[F M^ /@8L/ U3U5#Z_$AIK,X324SPY4WQ1PX7C=OFSKB_#]HR;U9=OA(P-LX_KR M.*!PW;QN76.K6R;<\UGR;2F!59WK)^L<0O=7J/L=WQ%[5KZ-;E+7-7$^OYON.OXWJSC MT*&RWK>0T;'VB^P162'I8._ORGTP'<<]L;_LJY8V#5_6W+8SM3<6=EK'<8]/ M5@%!U>*C_D+LWNJ)Y+L6%E'BSG&-O61\>S>Q?2FJI[ W5N0*M8>:6X@TDA^EV&>[8IZ#9T;-ZMRA2=R#YS7M]]&AXA?2H*2U% M'G)W/;%%#^=5S33L.[OQ+GI ;)/\\7#(?7*[QIZ3X<\DXO^QHAARF(U\& :_,@.D,V$+?0273CUX@NYENG@/&_1I/O@LT6#)^%\> MY@,3C :.#3 [--$VEP+:Y'*X%JNPT!_'1AF2S$GXT">XDO/%C@5P510HIN R MW&AHM8GWX8HGB$^*F#^/+F/0G0EF':W%3E2LI8P*LG#GWPIZ?9$9S'.SNL"_ MCP(,D< 3#,M%0;%7?4-[/>N/-_>M7/_ !2HV"EPO0#$ W\%@"[3^2ZR0U!^] M/YQ#21%)Q;_Y)I$ C>>T'J?T))#@:(DA24KB9;(G]8A$7*$IAE![S%/_ M?J%)%+*E8#07 JE.,98\:);P_LHON=5R0%I$*E<$%PK7:LE,VDM.T&^SO73OU7,P((+8X)5+S1_3=(ON38V#JUN M]._ /C73F:Y7>?T>G[KRZ*8'9:^!3R&=7CW]^_"]W/,<,_"7D5H662;(GXOT MU9OP%?PU^(.(X?"K/Y]08'FZ=O7W14_,UM2I:X;[F3,G?^J\K_D?.G.&O&:_ M'!A<.(82/9Q2:R&0#L?XAKQ*LDRF?'PGI?#V;1NW,C MWB6Z#Z8=_GAF64GGI7!^X!1*-_L4&,031J['I5BR/$R!0G^5=O82IY12U?:! M>.#H4I]_J]3_H(P_+ZY[&BM!ZH\7KX.!X8MK^G%RN7TJYP;;6%'JM;\ENT+ M,+BC*^7JA.A0C7&'[/+&?7H*Q_6>[0NK!R[D*P]@JW%Y7[1E'6M-PT]T&V6, MA![;M[@[^4^Y.Z/-]Q!LOG_C[4]K%8INCF=$*Y^]CR>3.;=QEX2#>LO&V[F4 MG?<3,9$O8]UH$_^L -^[@:>R64WH5@LF,:]D[GR'X=.C GQ+]S OWOBW'LB M7XGP2W0;DH+287MS3!D 2%,+502;#D"8&XL"=1LG>_X@5S$\N(]BFFX"%9-- M$[9 -2!0(!!R$PH#^@[6 ZL&L./M2""-4EG# ^Y;\<"-@.*:?U",$+D;T.ES M3 TO7PR;CER@@-"U1%++/L)2,Q[V!^P9(@7S F4 S5(''3E:'[GV![+_=#Y3 M>7O0:,3+'Z^F]&<,DVT5^X/:F'>]?8/G?2DB^.GK23#EQTMF!9MP/M0U 4!-Y&<+V8* S-27J2 M$=,NGXU7%;Z7[R=?X:,[\*PZ]=+/]E'@Y?:K6FIO:?K8==7YT(.8\T'KF27> M'%O0()Q!B%FZ[T-D A-"S75LM&.; M1++CB[.)WB<=(!9ES(2_!YBL*% Z0$:'J$$P<=&&O?=3#/(8OO<+SX)B!3[% M76^)$$86G/\\AC05V!W;?#\(-<-D:*R:OS,@-PE1*VJ7E=7SKG MKK*S.$53.960)9Z1>8GI)>)2@DY04B(NQ^,TJ7(4#9YF4BTZX^EB*(^28E#! MZV73G6JVV9"(W>PLF4I/"9#/$(;5&=1S]J0X+"?[L.7.V6\C8Q%Z/24)1.#I M8F68($FGB?JDG[:\%46"H:1F5:2&?B(A2F*]%T=][F21Z:28G&E3L2M0=3)[ M-VW1K6X2Y8;M/+V065!S%A_-Q72C/\_H];EAD2C?;.?I]O .KJG.9<6YF\:K MK5SFKEF:2M1#RV^51;9U/HXFKKD7#\@=1!AN<7X9R8LYKQ:^;%J@.'7\[D@=CP MR&MU'#8\0/V&XPN1=Y<$7=[G%JXCTK+ZCCL_TB$I9(2YZ=4S'GQ_LWEGD:[Y M+"ZDF\E$EX+V B^MDYU?4J6K^W2VCSN[+TY0(0 M.'")C%,KDQ^KTO*:((S$SEF)'6%EW"\7>VGA1T+GG4)G3<1<2+[TDG /PF=* M!$FY-QHTA%S288-[V6\V[.1SR4;'$3Y?%:O<]K9<4$!!>\$UAX[M[O4HZMJ^ M4$,88(#JI>V$\8' 6WKTX/#"NR[V%7!VW/!9YAP]?*K#1\/'8C: T^SQ M1H#EC1P; 8)1=D8NA%&O0.A:*XUGRJP#PO/*GT02\R*2+MAQ>0[H>K]#WAL MTUP#$/L#PBKTB"]K@+[!W_PDP'4'O-?C72?05M$LM_:+D,?=>5EEVW*?,,;= M1'!?S(UF^O2H//Z%L2SN?+CS F)9R3#\4Y'G&$DM+PV*[>XY*K;BY&P86X4; M"[I_/&34]UQQOW7GDAU8JN.K0-&A176%>5#=@U,EMF&0]*2:)K$222WYOC59 ME!II:M$4YC:0VO5.T"0&C2MLU8WWSU6AFMV31?*8W]T*1U@+_'!C@SO\_6:#K^7QTE"&BK+]%TOS/5R M'A]P!I$I]@P$_/LN/5[/;OL VKYKC3?+^GWBUN-3D^>#*WN@H:^+OT/67L7" MWCR/S>)F;]7=B7=8MX_GC__[OS8/-_=DQ8!J=&"K3V[1V+CE>S4L*N2U/L"7 M9Z=ES0?NC6Q.Y;FW,BIY_IIBUL<=;QZX)KRP/+Q0'7M\^=?#J>CHEO;P]0EO M:;]ZB)O3O$(0E,I(&D%R$L.PG-2C-5FB0!SJ< I/JQJ[%3N6\J81IQ,,1W*) MU1>'(>>SPEO)(4%$FQ5&)?H26:C.U<9/7\CQZX?&W:+B]= M?,CF6*+F1*R%[")(A.X7WX+UGOWG6^5F/+J6$]?<^97]V)WAVZN:/$Z-)Z[C MU+>:VY9S^<0KM[Y/9[1QF<[#1-]6E^4@#'H$:?'F8,\[>.V4P]S#-B],AO77^E0UV^LY7):QGOY:L9"-5E-%Y)EK%!%>ECR MX9+/#S'J*\'33U1U):3L) #[8:&CB970=S'@Y/>A)% M42RQ/XGI%3ON4X1\& KV.)9-*_"+UA/[8-#\:UA\0W2'&NGVXI+'D MDQ3"_(HEJ$X#J=- >3J -,3A$Q5P,W)!:-<^XAMA&B$8@_]%^_J[I 8528T7 MI$8ZS+;PSEUJK(:)$D?"$/, &FW ]5:W-&#+HB4O"933B)*ST W6LN/"=W\Z MPO%+.):]0=9TSA['<)@8'.A M.[&:;(M-H9:MU84F_."+P?J,AEEU?#AIW\%>A?(^)U.DC[X7&MSE>/^WW)U4 M1;;E_G+5,[JG!)X'%P;*JZ0MFW-/AYM0]LNWG]"!3%V_3UJ>BYPX6ZH^CNGA M&K3'L85;U'IT:$]_% M(;BP/1: V3> %YE.C_\+W-?)(6NC1^8QNH.,DNA^& MQ.'JP+?FZAU:6M/Q OG"UZJZC !6MCT3Q5((G3X-*YH)1>5[D7 \FA.+C<"X< M:Q3Q RV\+[)NM@]C72!S/,WPNAAA7$\VVX5"K9T7FAM90!))\1S'[B00/2LV M'O.&/\H"&[E5Z^2JBQ+#9T/(< B[*5T7*G2/%,LZ?JI4&?1E,]S\PMJXGD33 M'$EPI]%MR O6;HRWS"QXOI(C\W-^"JIMCPL)!(6?U M*IEDX_H19+F+7GC$=K7A1>@\E<UG/"94IHZ@XR[*GP1A[P1@[&TJ&X\ V!A)AZS0< MP0FS@=[3T7'-.,F0)W)#,J9-3?US15V]#B?BFO[R M[\PMGA"3^]*CK86M_[P^QOK$DU#A/*PE>2B@R(S$< M14D)CE(EFJ9Z- 4 7CMZOBQUP0[>K5Z4"GHZ;"/&+3NE,=B2,N9 MO:.VQA=.+D3#ZQ-[4_V-)Q-^O3C.X>;Y]@)/J]2/O:>8'B9P)C)S!0F-9A5% M47N2#$A-8F0*2#+=4R6EQP.N)R<(C>=7U'RXK#,_2I/>(.AD1$IT_$6QGHK/ M.^AF->IIR\FXF26 )DT,.6\-[-M")<\-&K E^[2ER=QE06Z2:HEI@4D8V;16 MJ-70[2<[?;I:,\6[09DF,(R,J17#V8\M4A*S.[5J_K:.BD(U#B9\9-\S7&Y MI,3NMBP%DCF1'+QMY++%&3\/TA;/325NMV6&&)1421Y6!)TE>[Y'-G5\TH M M=\;)FT9/D"N].M%J#OI@4FUJ_ *UW)E[>\I,1HUJ?VY85J'3:I=OO6EW*L5W MG^YE"?P^(?9LL>00E)1K6$2_U)?XW9:,-/)GYB!3$Z@@FS<2$FO5TPW82HG=/NNR4.B2TUO=P)7JG2BF7;=[EY3(/;?> M%CEI,9P*E< HE8$W51NE;F,"FY*[3=M&>WS+*,F64"M-F9E;-MQJ:HKJS^\T M;76H;&X(:@NCQDQ=70P*94N#O=*[3>\)H37PDBINU";%WJ2V$,1D#?:ZATT4 M3I:4%.>.V T&3K-(LK#7/7R2[30U):_T:Z(>=%)MSQSRG#A%37>6OUR; MI&K=)L$(>#M73C/ +23A4L&F.^M?RP[X=%U-:&*I4N7ZU;09: VW<, ]VZV M82FSQ:V8'J4R0H\?I+L6!.D>#AASF0IO55*.47/F^9E^IZ8K.3BM/0LKC/N% M5@FW1@35:U*)0BNA3B=3U'1G6KUTRC(K.5LUTH"\CS=*AFFAL29VI^4X'HZ3 M338N=(ITG)Y4[Z]A%F8A.E[@#70-O]+EZNGX_IQPH)_:P2PK<.NE9 MLTJ)+:[#X7$]G6CHL.D>=IG."X LY$A!;,45&V=PO"8T8-,][.(+[K!WF]2' MA%6ZGS6J,TU5"K#I'G9)^I;47=1[HH@7,K6:,609R&@2M8==0#G7[.18NR6D M/;QG#'SAWM.G$K5'KJ0J9E\;T E<:"VX.P6O..5D!S;=)P04.:Z4 JM(Y#R5 MZMXU+"L[@6/=L["-S%C,#7LICL"+ >M[;#RQ*"8E>L\26//2V,A6I[=".IB/ ME8#.E4A\BJX_V6XJJ3VX/=&]!(0=_,-H2D_B29*39$;3:++'47%-??\OGG#: MVWZS(\OZDU$9'ZB6+,B\F8/;2!?/]. NLHF;7(4F]"U"IN/K"%=+K6;TCT M'N:P1R[+FVT7#L";Z[T[4A%T&?:ZASD2H_[T=CIK [%#WO<[-)/SQFH#-=W! M9XY?-#/%J>80>I)(4*(XSDUS?=1TC<]O50%ZRX,;IZX9[C)J"7]A M4\%YHX2 [80%!-8W!E+Q:"'.8"'(:X:)%N(<%H*X)BZDSODW7PDHFQ+10IS! M0D2RZ5P6(I)-AUV)U[-?WJ>W?GK6_(;N'2KC\6MJ[176D4?7O\&7'[W=@8KM MW-JST^B@UVE_5-<\"/$^<\W#2=5#H:1 M)W<(C69?=X/09S&TO/ON,H1GQ"[GP"YD)%\C^?JU@#EC0/P1/%R39O9;(?8+TY E1=+ ML7T2Y*>>SM=O^RM@GV#B;ZFQ=[#E7>YCIU[>B%M_%+>>G37RT5TE';@N_ Y; M;B W%V-M'!-\/P-IYPBK2S)F(J;[)DSW;8V&A],RW%+4HQNL4$$P!;T XT"? MR.;R#,DW,1E.P-9GH:W]SW?5OS#ZD8O1 _49.NJ:=64EO*LEL'6_B'A?ED*KA8R8[O%9V1NFB6H+'<:AD5L\%B<2,8)A_OZU38O#>01/S]A+E )&;/!#',!CYVF7;G MJ435A=HY)SB\['C2FB=[0X&:>-IP%@Y151A5KX*;.4ER,B!,_S;*O MNV DZRH&9B-4=&MY\X@3;NK**L0LKW*4(DO_'5+N="G:7UZ'F7:MX8C@%#XYX5IST,HG(9BA@L(DV!@9YW^TSP'51X7# M:#N^;&+;*7"1W^'"#;.#2[8?9V\=+83QBM2ZEY5X@:VRJD!U!)TS.B(?)!JH M:"<*6M Q)@[_1Y)1ZD,$V0BR7^4B>06S)GX_%QBIV39JVD@H\(5,7D1%5HDP MP,''*)2R]&*ZTO=PA\ G%VRX=GT=E:QOZ1:Y%R[<5HGBOA>O<+P@P^J.[M2F7J(A4&-W,>W$A>1X'-[P@<(@ M'!TCB)"-AR=A!7:E.^V$!#X=X"ZF_C MH*B[S@@.?![F9J#SGR,KO/DM\E)$5M&W$3#'RZI8@J=NRK:?M%5AC1]H'>V1 M.9.9>)NAIMVL6&OZ#&\.<@6IVT#W?R%%(AXCF"/J$1$((Q!^SUW^G2BTF P; MT*V48UBZ98\5P@6!WT230\3_&:%]2-N_5'<^CWL M4O3DEZYK*>MRR,;ZJE!"RW<48P"_ Z[WO_^B$W]A*+#AS[&#WNCR(W![T2 ] M1T1&UEC$=!>R#5Q&Z'5]WGQC$SCU'J6N1<1%QZ^5PZ_D_H8 M!.]*-CGEVEJ.R(T)2JUIA:X43!$$4<9+C&<@!(]0:N0"K,K750+?E54069F1 MWG[&>OLE*A-/2TFOA%D;P>UY2<8)GI&K@LU0J4SA7X;@..*\S5C1$L M$:,31ZQ=5)XX7%+A"NX\ #%41CDW$ M:([Z.=FW#UJ'&X 72\";CR[OR#5QMH;1-PHP7:)*L3:.$)C6!9\W8D4KH11^ MW![(=@&.QP6>OQ)<>X15RI@9BDG.6&/,C(?BO=Z4U=)4HL)*:3P++:=C'@V* M\!GA\WNI# <'J*Y[4EX4BW,1]/(CAIS?T:7[$*!AY30F0<#R$3D\H@0'B'\;#2==T.\*X[ S%1'Z/Z,ZLZ,ZL8^HC(=Y6QM;SDLKJ$'JM9F@:D>L6 MAME\_FY.>DF)6A9HHV($%QU1CK ;8?>+-8VW@9?RU(*;313+(C5LVSK>\OE) M/ 0OR@1AR1A-_\C";B]?<%<^0O3E!YH79V%619'DP28+21'PX34 M,PG9U,1XH) IOS>5J+!8&Q-C&#;&LE&]M@BV$6R_2O-X$V[S,YQ*9#)J2>0( MU:X%UK@\8),(MU#Q8%'Z*<0N_=,\'&G8&_PYTC'@@GDZU(QE-._(UW&V,>23 MN67/1SQ=5I0E%7BZ#3PO[5@]W0[A]0B[]";JUH)L7G5LY7D-A,K6Q::3]T6N MF<@P@UQSJ%8:$L6N+MNE7[PB//)_1'C^&7@^FKYQ:$!W.2=I3?K3#I&N2'BG MT-"]HMQ'@$8IJ>1Q;KFY )_(TPA,#(,$P-<9J2/'/:BFX3WB+[&8) B<:+4,JU1.B5 ?H?ZLR*5I?RY8#7)>T#2Q5[^#0BJ^C/:P M#!>CZ2,>]XU@&\'VHF'[%4&??6DF/1NT>D:5$'$SEQ73!.<9MTF$6^12B5$T M$^-?C-)>C%/EQ B.?"=14/I8\NEA@E'MRHA;+Y=;OX>I&B8+6);NHSM[EQ4B ME'700T'5\/] ]C[&_AF9K&<;:OQ&Q\^/M3=$3!O1&\@N\"1! M#D9Q(]E,&UPO2YN5<9U8%#X=."A4L^]P03[,(MPBZ[);R*KNN)#/RPF6:C9D $MQ=?MSP!N+]]#4?[&?(\"Y'[)?10>OWXLJD MJ9,BSIFW25)D2VXU>?4;0A3^1^YQT#[Y !O)+C9!S_GKK5F$*](16EMI5DM] MW "&!KA^Y2[(!,E3<$SA*,3GL8,NF;+*,W+W6S&RSE*HW^F;'/8 MJ5LYO!F?&J D=/#<,-<=%%+9<@/EEKZ=6?2P^V5=U,#W$%G@]H?)'N9H6$5V ME0%&DS$,+778* ,48/6 N_Z4C+QBD8/BZR.ZF\N'0(7K,WRY=C?Y\!])MCON MB!Z/.L9XXJ4:W92\2';[3W_[J?$NWZ*.(+D@QLWE)ZM[55:E2M/G.DYXN;;^B9WCK):EF-?M$&Y MG,+[K:BRT^BU&U2W;U I0^!4R1[YMY=J37Z4"!K;8XK=5ID76JYL&RVG([/^ MSS$E-\CV-CO2\.5JK9]W#:O/$V6%'!$6GSQ3@^"P4Z<8EVTTJ9E,E"RZI0M. MNLREH2V4^(96Y#LI]X(9E2S[$KUHI/,$UV_U[YJ9IMBUH9 AF1A-T+'XGN() MH2GT'1CJ!;+T)XUR1RQ;92-7;4VMVUM\Q+G)D"P42\<2S.YA[#7OO$'-L$3: M=+A)5Q1S.:Z3'5#NM*F?1,U86L#;2L9R?5^?Q:+LI3K9@ILA13 MN:1:#Q2QDQI(IM"?V2,H_.FP,CGY8D&?* X %AOHKNI6<,; M$7)]P36G1B DJDD$6.XUP'[+4'@2_AK-4S:A_:FK\&>8(H]T7S:CD$'D^OP> MA\".=G7K W;J$#H%.[T$SKZ:X2W9S@UR7D#4^BD=C+)V((.&1(CN]0B#'Y7#![O^M4W@_ V*3;GMPP_$;B)1AD5T,G2:@A"+@0A01.QQ!&J M/EQ>+".I*($5F,CQ#5=%TQ7=C_P,4<6;;USQ!MDZ?UR4\M$$OJS;0!5DUX:4 M\C8PFUE"%HI .-5_KO!]%T?RR7Q-=Q(*,6_WZEVN["NL-I7HL(PXE(,4P<$BT@.?($<.)H"]#E!<-LVE2[9:+"$?BLUN-Z$++RD12HI?%R*D817.Q.+,O^R9RK$3PC>![1+WD3?B55:58 M+&7$HB#?THH^S][7N4D#X1>I'VR,8:$MPGV+2ED'+\X9IH<<7T&)#+5G#!<: MB@K5"=#=O"<1A/_SA4;:">;Z3=6:#0 G;?5-0O+>;YC5SH@J&92CMP8+VTXV M[_H2'58HAS9:G*=C1/R(M\Y&(N!\8!&)@,M7C3X@ U*DWE9ILZ0901!/M=DR M27K<%,D J"C19(SCV1A)OJHH_?)1.?2S >G!V42!JA1PGVI12(/"V*46-0"8 MK"B.!<GF$!V$10'J[$]H I-8 U$XM]' MPCP[W__U^;@'T4#KCBFX]ZL\;\QJ\$RTYD*14$?X#T7 MR 8N:_#!-[(YE>?>:I8\?TT]F)0W#S($T0%CKWG^W]CC2T2-'5):\@S?(-B6 M6KW\U?JC4&:L/W.\,$Q\XP)31JG3J.^M7L-5\9W1#45>DN.<)L>OED_]2GROZ-C;>N2*1CTH7>&7I:"G MPPYB6,%6(%![2[(LIY5>8SR] ?'6 ZX=K38*;]4ZSYD]C![;'#[V.'[$%ZL9 MP 8/$-.]U2VPW8X:=:7H#;QM*56&&8+!<,N M"-9])RF9E<&]D&I(U&[+1&-&DTRQ*XI62*HNV):2@"K#;,CV;*KPQKRT$ MD.C%;9\F4V8!&@P2^[1EHTV)=Y8WJQ"R)0GU^L";@'I28B7B:$-5!23L.SM;LIZG/GZ2Z?G)H2WL0) MRJWXUB39=XN=OA3??7HEQP8.64HV"#P_7_1%84Z:7D/B=UO>B>F[\J2>U BJ M.:PXS5*5MZM]*;';LD.YMYV!I!I"K2*8"T+%)34)UXC8;3KMLCEI/%0L8YP8 M6;9OQQKCK0QE,!S]FLE,I3:KT?-N6>-A5FO&&,_7% I-UL MI6<6VPN[WT!JY^Y86P0PJNQX2. S,>T/7:T)!RN1]&[31'LTM7#?:(E!ET]E M$638=,^:3E/#&=.J6%W!$@VV"]*FP@XA!;C=IO?VHNO46O%[@O+(;N]N MHEGI>SC6/6NEJ:382VN@([9<_E8-J,2.F^#LH^GH=- M]_" 0]_>3KVQFR8X>C*V[&1[4.1ATT<>")7[!ZUM:;U!C-Y5[ M<*,-?'!D37'O.<5E0_CE6[TAC[K]D<->T4)\T4*\EO,<+<07+43BFHX6XAP6 M(A)-9[(0D6@ZDX6 HHF*%N)P"_'>9(/7M-:OFS4_\O_:\;Y\U15=Q\V3XC_I M@=HL?+U=!+NW/7]H02&B_'/%7GV4%D=GB,\2(^NX*.B!M00WT4)21Q'>=/FM[Z66*A[*L=PD2,<0C&X"Z=,%FK.BPM+!]DVH<)X&Q@?NC'Q1>:@"'VN""; # MX%V*=GE&*?'G=!3P$.GOJUWN8@X!'KHD8R98Y@1*I+0Z[])V-@Z_>.:HDLLG M.E.AE%QP3L]JB=/*)VH5A+C+NHZ%DE31%#JZ/T@''B0[< NV8@:(N$G/ _#_ MU;8\VY,+G\R[\'_B[.'K-5VAAZ!GVK-G,4)/W02Y,1B[^N)\JS)_Y.)$B$D8H;7 M#?YO0)2?8?^G'<]?ULX09B-T9LJ[B=P /Z/4\FN9NE]17O!4^U?$EN?,EB]F M:9XU6UZ,G?7)FM@M:)TNMPW8Q !^>(57I%M^G^C1CXFIGM;Q=%3_<@N8)O(K MV6IE#=*5DK?'OY2_Z^7+]1)D=WA'. ;74H1:MR5('0V!'CF562Z68 ]9;/(\+>0G MFDT;* /;,9W^@2X3C8R-,SK+(OJ0 %4L)>_A6\?4;5' M"@GX;%D8E8G&6_0^3YDWI##M@ U4I$/A%9M71; M]WPW/ 8,^TUL4#=";UMDV MZQ)6)RQZAFI)QTB>BK',$56/4W-VA.C(F7'..LO[$=UWF(3<=>XS@BYJ(_7. MN2-S]U.$:"Y,AX7&!!O?O&\T4+55J,[$^42,(UXRU2+H1]#_9N<&$ %(ZJ^?Y([8NB!K-[TOLEV^_LKB M\\F&/;XKXZQI\;UUAK75M+K9X"'PZ^WS? @XV\L%@XR!M\KEVWZJ0LAZ/[SD MY^HW&V,X(L9S=.3YB*3'E[I-SIH69R,]CNIS>8OTZ T41_)L?DJ,"T%B,G5+ MB_OQ%$D/=%%IC*6I&!4__'G$<]>Y0C<+.N>Y=;E,9%X=SKSZGK+PW"?^W4)8*MN)8 $$8"CPXU7^N\#V23RQG&DVNP+%B6J_?):9#^JY3#Z^>@7H3 M$Z-(-L:RNQ&C/R,Q$(F! WA6?K(8^!JMYVUB@"A/RK).[D)1?V\]S%6$F?3- K MH,+>P/,QL!3[D5H891B?[YF!BW?ZKN'V?!ZQJ\U).9>B-6-N&40B/6^* M+@.GKW[3,7Y/#O'A?+RG9MX(M-_P6,#%NVA?!ZV9%'(&+OEY8=PH6MG:1-:* M=PT$VM KR]&[=; _[9&]%,5"#\W(2)L_6VW^5-[4'Y,U\R4:Q=);$_IP]@BH MACSR:PR3, 00[T[ZM\GF/,$E)3*^/&]()<@H/3]"[!D;ZE]\_<:7Z!,O0W:8 MU0?LS"9S1,UMI.I5DK2G[1"R*-4M$:.)E\X'_Q3_17H@VWT E0Q,DW47F\AF M #!'"Q<7=@N[0"\]75VEQ46FTH6;2F<4^ST?<7B)"DQXT' )WX*=A>"]1=BM M:>D'Y*8W@;M'0L9%9B$V TTEYG))J8[2\T3+GTID6#J21:<.J9<.7$<"(!( M%^M4>:H/'>B\X9GO]LL0=>11N/#CPU^#NMSXQXJR&186%%BHM<#1&4+_Z _T5[(-X.Y9SMEU*- M^M0S.FW[SFP1=;X83!&4D1>"?NF@[O=W06Q5/%CJ)H7#ZB8_3]F.3BM'M0XN M01O:E9[/AX?+ =7T+*V>$SO21-*G UP;R4DXJJ6C@H\1W$MGEB,9$LF0J.+! M=]3#WB-$1".;O"L-\,"@.L6B[*2YEJ(VD!!!FE@\EB#X'U?WX,7S#%7@8^@X M972 X7,6)@W1KSI!SP3G(1NV2'2@.^G/?M+?.2D6 O5MAY]'PZJWD.>-.S$H M)U4G+>8%Q9M*%+G,C>6@%&02Q\R/C=!_2S;3!];*T61G7B47AT/H@]8X=09!=&U+-@\(KE%VA MX'II9R@0E;NI:P['0MJ_4^TFGIOG^E O#&N*$M?4;NWQZ,A4)/M>DWW*).DL M%O$L1^#-RJS.L=E9JY_\-K+O+5[!LUO#\N+KTL[.;NH'#\.N1":AM95FM=3'#6!H@.M7[H),D#RA^W - M]Q7:JX'5 VY-6Z)] ^QK4?I4@K;=R;1U/VTD15!6N_AX@PR7VX T)V C@7' M,$=:F.WX\&'(2PE'K\-?]]&%QB/9]=%1/G\ /("X1D61<34\SX>\[S)2\33= MEFU%A\WAZOG @L_VK@\XK\_+3E6?_/X;_EG_3C&!["+),5AU_B 8T$-6(I,@ M_GT4@&^O#<5L*,_+*5(;@P[__O=_;0[^T6+$%<=TW)NUD-J8U6!IO5*AO.H# MO.<"V'F0= A.F#L-<__&WM\B:CQ_]E[S^;$ MF71A^/M;]?P'U9RS3]UW%7B5$7,_.U4$D7,PX=0IE9 :$ @)% C^]6]W2R(8 M[/',@ G6UNZLC1NI^\JIK^L(E#-Y'=T#V('?X'TK^ @+MN ST]807WZW@(Z' M>J)G'SP58P5)8YIZXB^$E%?LP>Q)69D86T@X_E>KFCH5;?AYP*"%) SB'729 M#K'$EB+ECU#E(52/P#6#T/&13%%/7+!I)"6E80R0ZE"E)9J268E5!5X:Q!5* M8M0A"0!/D0(#OGG[^$S!0_Z\7*3H#C3X@ @JX7W:UHQXQTH%PB>U)WN:6X%C M#KU[C/9MGFR[>V)_^\1N_YA2O!.@F]1-QU2F8_A=8-G_][^8^#^$N'"AG".V M4+G\ 7]VIK]<0W95:':I?Y]Y5W\L\7U.B ]E$&Z4V$+BQRM6:CLV,X$J*?+UTF2-E;:8W MJV0T.E%ZXP'7[[^L)/;X]299;)*E?CXJ=LK96M,J%I1%J M8B=FC)Y;29 2EW@I\WIIL=/7097JO9#%<66>HN8CL[:I2[QT]%!J,MU,1V.P M:%>E:*=,&Q6*;:W@RJ,SV2\2'Q,D#$Q&PYCZ8Z2@"N/S]2MO+C155Y*MJO-@;T26;'9E/'2HS.Q@KPLMI/Z<#HK M-Y+#?).63"LAQ8[/])).4^.II$CMJ#.VBV6[V1]1=;B2.UJI9_ETD5ENVEK2 M2;VTF=6Z*(W@2HHZ@CZI9LEUIEHGBY.^,\M-RFDGFY"$X]>K=5W-Q=;#&1LDGNE5861..VLYWK=CA;XY6\&51QL5L\MX9QG--PXXGX,KCC>:T<3,[H^-#,LM*Z2JEN2 ]&*$YW\>DS_29:+?3LL2- MNZAVQT*2$5MXZ1'M4]9BEF,I84IF^0(I-NF!KNEUM/1HKZ ^+,383#W>UK+Y M6;Y99J$LYQD_)=JH#0"_9-9^IX0C-Y3W:;+:4>V'2W4)>C,[+ MG7I"B8E6%H_P/=JL,5C51'==T<7%IEB*,JQ2!,4$6GJTV7Q?'%#CA6Z3"S+7 M[8^<,M465VBI\'HI+T[Z:TJOJNU%7M*[\8[&OBAXM-?17HTYJ&=ZT7*NO3!R MA4:B+*U:Z3I:>L16K1*KM(;B.DI&&P5CTIH,-\\E_-0COHK/XJPPZ;S4V]'> M3$\.8Z->K(*?>LQ8:VN:?3'U_(C<+!HM93.F\\WX3.'NKD*E&?P>Q0%3+Y[7L(*PNFG M!KKO+^$7!TOE 31L7 =;P$0HFVX#$:%LNA%$Q)^H$!%G1,0O5L'_-/S]>:<6YLY! M 0A.CG]64>>[4OF/82#\88' _EB_PQ%_@\/S*Z:.@/*?;Q3S[3>!P5%/Y'4; M,_XIM#*FA>KLB-;8 H HPP5CFQ -%:A$6;:4L0<[AHIX/Z J[D- WAP/"4B(0N= ML^W$^Y&KNX;*S;G =Z!I'EUX;"TP]GN+N,F.R$-W)6E>=LP^!R[\FM:D6$B MY;KYR3])F=RQU>AU9;D7/?'YV>K?MA.XI_M.52=FIFLX(6& M_-)Z4>B-N4Q6%3==T&T4J^PL/DOL]_G/5S*_T.G_J*7_B6[^B>?2BUA[V9@D M,#9MI4DOJMG$2.)1OTL\]8.)Q-GW1JK?.0M\?OS(<[.O?>YSS QFKR7'/\[U MQ)EG E^!YW]EML=^SW)O(R=87IL427-=B//MCC$VHY7"S$T)B.4YQ/),R.OG M-F.O?>YS\/KC:/A/8O7=E2Q4\)DW_+2LS_:9^$I)F_/)9+JH]J9E (VL&4(/YI3ZW1_MV(^=8@X)83#'@>5IZ&8J5WQ[@=9+;WYR, MVEA'F2F5*9#1TR_KTSOA>4NBV^ M_V2UK\LDVRTMV0(937:; Z'!MU;2>9GW-<]VF^M.DDSW*R(0%HU6DEDE6@DT M!85B(<]R$98C(S1_S+._$Y)[T[F[PL6\IFM9P("@P9.(%12!TW4\&1'-9E*\ M^<6V=WGJ[J/J#Y0'/).2/M]HW3_URN-ZE1K9/;74KCZ3B9>)+B\3G=^(Q$T' MAN.'X?*V[0(U8:@9TQH"-+(+G@%BH@8A:JK>FO?TN,,4XLJZ1BOM36.0[8)R MZ3DGHGE#]+:!2EU^(S*$34O0YL@]?A4BOFAX, MU=7O6I1GU57OAY4ZE&7*BV1_TNYT%V1M,)L8N?@OVZH?UEK/LNZ"=YW/>3-M M,P87;7UAD/95BVK.AL9;K*P) MB?6QTD.A9 V)]>L1ZZU6,H34&E+K?:3?WR36F^L6\ HQ012'X/'SO:P?T0S3 MR7<4G[_XI8X[22P?E)-XD9/C=#+^-XF" ZF]V,")V D3 _WB\["DBHM&=3FK M+7)E0Z]+<91;YI@(%:>?*YX[S#J_BJ)4 MY^A(]L.$+!\Z*W)I%7-MY(5YYP?,.X=$&R9)[EW2AKZ^9W,EU(EK.VA+=LM\ MX\6G;2]LK?G&1@/ \]B0&IK 6FH*\ RW!E#,D:&]8:@M:5H1W'17)(NK]G"F M534K;B8DBD01 CI"Q[FP\T$H8>ZI:"#4BR'5WEWQP /%#ZZGRU;+.<5;YB)% MTFZTV8G'I2('1DB7X?X /U%FMUZF 9]9 0ZAF_;YH@KWR:.+F#<6<@1*T<]^[URJ6$Q1?;VF:.&LN:V3+;A:A;R!1 M%&[@QT1X.A9A3Q1HAGT40FD0A !"87"Q*,"'^9A,,W%Y,(K/Q"@]H"TRFV5> M)G7,Q^P'^?@.JP70,S\V9Z,L6\J88,(Q&[^3Z3KD< 9RN&JZ QW< HM_TAR. M\]W16 K1JKKJMFOMYC/9*G,*UV&$^F7'<.A#AVG,GT&.;!:ZU5+.;62I_@JU M(?7F<# D$XF%O?D_I73CZLQT )B+#NJX^E&OW.;W,X7&V;L$L[K27TW$::&= MS6<3FW8)],T$EAGA((]/2PU>G8/.+BR^D)'Q.<+B_0*;6296[5*T+9*\/)LM M8L^M5CY^6<'14WI<:T!-%M.%IKKC]4LCPV5&2'!XHT!8EHT(PGOMQ4/Y$.19(1FA0BM'#)8&0H.FZ'G*JWBP ];+S OO/J32;6K98LFF/4L5<8C$G#8_K4;D1':$9/A)C M?WK/Z=^.#%%V,UPIX_-)[)"* 4I1I9A"\Q(KD#%IP Z!I,1D3AARO$J1#'S! MO^7@&V@6@TRUV3IH"VTM3Z_ .DI2Q7("19M?KU2MH9BKQAA]2C/+KLB1&X9^ M64FT%'N]DK6K12ZW'$_(#4BD2N49GU:8$<3\T3.;Q7)6)WFM3X*)GJAEC>HX M-UO!E4?/;&:I>#&KIGFQ&.=Y=<&D!VT] 5=2Y.NEA:G=R$BE>5O1[XG(%5[)'1UIO[$4_L9R+33:?>EG- MQ+4IHV<>;;2@%]/5PFP$IHM&-9L?9RNKRGH$5QYO5,AWF[25;\3:E^KYGHK<1%99Q.OHS%F;1)2+QT]-!FK6(:Z^?R<-J)CC*= M9EU/+U=H2-;1F10Y[69CS$N4C,ZGY,AP#$7CT6B>HS,EA%6OHJ>6M79'':W= M>J^LYEOH[<=G,E^2PMK*R*:X 6V]/C66;IG!2X_.E$\J&S&16LJBW&[--SF. MX5GW8 J!*"UXVH^B^X]%*N>V4>Z;;R;7Y,N"3L9@C MM@OX9N31ZV79S2MI8]$FW;Z>KF<2+#>1ZZB>\>BI"OT\&9'#SDJ,=JB2EM8S M@&SC,OXC.LVVT]EDRA![[5DEFN$T>I8B"RNTE#M:FA^64VYMF!*+W:5MR=R: MU=I>0>719EL-%PC3'"6UH_$^L\C&!M%B%>=QCC;;+0L,Z]1[+-QI8SZN4F"! M-R BVYZ Y1'NE MCUD@71H);766<\19PVYE)N5\W?;TP1$/4,*JQ,V,IM4NCM1>)IW0NM4A?NHQ M$W0F,[ZH5[LOTZB3H?IQI]L82=@KW7(!5B"!F/=M L74=7EN@^_!#_N* MU1 M'7L)IYF\CF+%:@2Z(ZJ#H?-==ATS^ "K=N\3WXKPUNR9%?X:]$G@[I#_0AK( ML8*-^2^D/,WTX5P=_6[[ 55;GGB^"9\YU,U5H.B"WZ/(J/H^L( \C:X@G/Z9 MFS:.07RW !JHM02OGNE;5OC%P5)Y8)NZZX!7![VT^MY;"/_X41,;GF7[[T5K M'D)$?!(B?M:O)T1$R!%?"Q$_ZR47(N*3$/&S?G+7KZJ\'_[^ MO%,+$]'%U4^IP7QI6_;"8>%# HP'&#]PF6=_;$OAR-@7EW644P= >4_WRCF MVV\"@Z.>Z.M>POY3:&5,BW#&@&B-+0"(,EPPM@G14('JW77R8,=0$>\'FJ2I M0T#>' $>VDPG!>#;PR I,&#&<[WJ/?1QZ%$X#,?L>+C,=_K,J*3]'1K(NG3 M9R;I)M[@\JGC\:Y"Z@\.@=M#2#Z=^V?^)- W;0QN+O56PN,_5T+ MC.*>8M=M8?FG)IK7I< ++_ECCD-+[2O:ZNC>>31OA.B_"/JA>1J_K'+]8U]- M4=R9J\L.4$,:N#-+\[9A\#EV96A%WBCZ'R=E^2?YD3LV$;W>=/>B%#X_@?W; M1@'WQ-XU821FIFLX(6&#]4RCZ3&S9G2==3JV.I[3)M^FH;:3&;)O3 M)ZO+#DF:)W(#8Z 8"ME9Y ;5?$ZITUW4>Q7-2*(B,8Z/4&0\'%OP"3.2/O7< M%QV!=#M<3URD=?BG\OS9>X\/C7&L49O&ANT.6$1[M5KMF>F-(,NC$4>4$/+Z M)\P9N#M>?QP-_TFL_OZ$HE*[/RX[2;8TK9:X7#Q3VM0ZW3&]EA5Z0]L#U(]=^/:#)2.Q&!GA2#;D_I#[?V7^T!79_Y^+C1?Z;:9_8[[0 M0C$7+R,^5VW3 Y+IK[J=K# X[X"1-^<+R>QX/7PN##2R^DQ.*N65&5OR2-NC M-OP4'Z&%>(2,Q<+Q0B'COQFZNBV^_VP3?SG6FC5:-[GVHL7E9GU0K@TO/(9T MO=25O-7G4F14J"4V(UJ,6R_(*\?3@=@(*U 1CN5^-AWHELI ?C=,YP4Q",VV M7: 2+I2Z!%@#2]%L0)A#8B5;E@S%<(0P@(,^0 MQZ$XQ;<(TS]0 M9O&:$;NT:\GH41(E8=ZFI):YG0-&_;$OWQMJ]>+@.>:V._WYP-Z\=,:)V6\, M.9\.("]X=)_'9._]W(:[$'W2KPX[/N%7@%,=YGVB3R&:/R%/LIO>)FL["9'D M"\]LO^6D"F9L)<50E(^.D&PLPO#OS1H+&>>6RVL>J*#F>FK_ZK+A(T;$D61X MEG47_(%@,"EM^KQ\3JIDD8\74YEQ?F3G1U P<% P7'!:\8,SR[63W*&]<&," MX?UH8'G9&Q9H2NA-W1PY&K>A*=.JCZXN'#9FGW4X,NE,%\_ECL71.;O?15:# M\.U'/$+'V(@0#ZV&4$9346=7/SPU&TCKIAX79X;5&C?;&:/<1NH'!<$\_1.G M?CHA^T&KU[!O$1W(-D WX69S8-@8Q=\?)FS_T,5IKRXZ/@S2OFHYU=G0>(LU M52&Q/E9B,)2L(;%^/6*]U1J6D%I#:KV/PHLWB?5AB@V\O WA-W8-(T3WF ;X M:/#D\>H&#DJ,O!@,W#E$10V"U/2K"/"_210W2.V%#4Y%__5,73:%!B-&QV-Q MUI!*R2R_DN*H9B!&1D@V3 ^&!0-AP9990)Z[MH"W9+?.-%Y^VT+!-YQL;#0#/8T-J: )K MJ2G ,^\:0#%'AO:&.==@A$4CN4DGQ6*%,V=%,F6,I(1$D2B00$>X&!^V)PDE MS#W5=X1Z,:3:NZOS>*0PP_6466JT?NX"1:^2G4FK^%*>)HL;:H24&6[B\1-M M]C E-17@$+IIGR_X<)]\?O6IAM?65(^OEICKX_>B 8>0=A^7=NGKXS>4NR'M MAK1[RJ.]7>+]YP(M.,\:-WNC(2?-)'IF9M84Q52% RE^4M%U^;=]#&CBY@W% MG($2M'/?Z\79;8JC:#,SRHG K!>;<78JE1L)B:*\9IR16)R/\-1QKG&& MTN!NI8$?*0B%P<5B!1_F8SK>+C>Z_>U!*66>PILQ'F8_:#?/RPI0?H MS1^;K%.6+65,,.%@G=])FQW* 0;* =5T!SJX!4'P29-WSE=KGS(:L6=^4VBT MW1=W$*5T*;IN_,D%G \,WLG"TW3GMB"1T>*\WN];[>6+-4)]A]'D'28BQ)@( M1UWPCLVU>>2&ZD"NSDP'@+GH:)ZK'_7:C;T_4VJZ]6 M.I0?H?SX]=*;JY_U*O.#SARM?+%22:>[*=7:O&4N6D.);]*-3QH?Y"Z98J,Q M%7JBW!CE>G$@# OZ"@D.'+(4(J3 17CAV/((YP>%HN-/ZI^N?M3;<51R[&0^ M2VU:FE@M#RNY3+PU$OJ7M1>4!*]ME/A"$Z,IBXW7]44?Y+"]@"*<#!UA8UR$ MHW]ZN>K?C@QQ]N/_J=KRSY'RM*/ @"[V/G',N?LRW,;? ]^"#:!W_=NN!F3.SS(.])8N*Q4 M>0>GWWZ\,%:YGK5?EF%AMSJP7.[GH M*\7ZMQ\LPT0H^GC&XQ/^)*#CMV3WC9A49]?J"H0KL$[=FH7BF\/[;(T!(2NH MO[9L;"#H"00GFY M^+%!:/#[(TO6B;ELX=ESSAC8B/!0:LQKS&W@["RT_55B MZ.$/+K<#9\!^.N/)W@;P;B&Z#OQ1"Q8KF3W5J.A MI ]-WXE(!GTRD.->F%< MT>P>LKP#,WN;QO_^G__O0WI][U2^BJ>QEAN!Z, "\C0J#^&+O\OZ2M[80;A, M>*+9?^U4J[\KQB,=0?@7L?L10>,(E#-Y'=T#V$&*U?M6\!&V/(//CNR.;Z^> MNE52-/7$7P@IK]B%V8O R<380@+ROUK5U$D21#]# 01%G_[/?FK8_PCR&[9I M(">ED+R%#+*E2/DC5'D(U2-P[5N&U!,7;!IK:Y64(0Q<465!C() MI;JJL@.2'0IJ3/:-L$\21,P.L._ETXON0(/?CQ#0DGC:)M&]4Z4"293:$T3; M4(1M#E.R/<[HYDT>;+MY8G_WQ&[[F$[@ 0AX@I6]/?HGG8(B/W:,OUQ#=E5H M4JM_O\*.-*3I(0 *D!A>%B260Q:B0M)2;,#&>%D=JH,![:-&#ARS,14MN#*; MDJ?\Q*D\/SN4B3U:SM#AND)W%B.UQJ9K8X^L2?;PR-TK4%E;6 MGK5!KZ16Y55OK697T*0Y6NDT8E6Q_&(#D;>'W5EOFD^,\4KN],F53K&EM&LVZ.5U*@SSIU8I7F>YD20HT;)%O+89,N5AT.W/448]_O3*SHOJ]V=!I MMHO)=9*N5]/=W@A?C3UZ:&(Z))/MJ*:(U?+8?F;MK#/,X>JDHZ49=@ &=BY7 MG,K5VJ \[N6Z2P<7(1PM;39'_&"Y= LD75@O,J7I#+09N 'F>*D[S$IBFJL7 MVIN^&L\*G%I<%>!3V>.E5>YY:-32-8$LQDID=BH)1G(-EYZ@$XF: '(DF=PT M*^MY,\Y/F_H8+ST"5KMH,E:2K2>GQ=[<6"W$NFCE5Q)U@J;B[1*5G*RS&KDH MQ>B2,2D\IVFX] 0!*'IQR37=OC#M%'KU9;,R:8$YW, )"N"EY&A5Z\=FY"8E MJJ38L*LQ#@+K! G(C4%MP*2R@W:QDNH(TW@CUX4D0)] [$)/MM/3GA4C^4F\ MH_:?8W.KBIGZ3JRAXZ1$$'#YKOT3)&4LNN&F1L<0IEX4T0)^@ :';':1EAB7):HF.]9?K MY^@X#9>>H &QF%_,>6:RG&KE5;/3ZKNSZ@PN/8%805]M>J51?CDM)IK]N!LS M6S8]DI@3B*56G4UC0P^$]F99IFDRX3[K*EYZC-AJN3:R[!4ITM8J-G>:24UL M)I#S>?34TGAM;J+S58+DA87*5(P7EHK5T=(CQ%*-3,G6&$@RFC'(.F-F5$[) M\*DG$.LX^7A++M:R8G6TJ5&UJ9I7U15:>DPNUJ1?K:ZL!IDEZXP\?Z86/ ^7 MGA 9>JM;?I;T46S:Z64R!4@T7'0!(7""7#KKU:H)$GEJ6ER.>& S3J.CP:>> M()=--EK;I =V4]QHG5PUNYDU&B8\U@D:T.(;>I7+Y#9BJOT\6)(4$%J=.EIZ MI%SHI+-JY].;TK2C3<1DB]DDGTLKM#30+A\+S>U9',A8]RU39,4JGO4;^%G8 M+T"!P^ #SRO GQSX#OOUFMZ:8]?,L8*-[84TOWVT#C7&/+'Q]\K(]TSSO>>; M\)E#:*4%'F?P>Q2%%[][CM8*PNFG/LY>3&Z[5!Y Z]!U7D=U/\^KIG[5J_;_ M_:/$"?U$AXBX!4103^R[70%#1'P2(N)/_+M7X$-$A*+I:R$B%$TW@HCX$\.% MB#@?(G[Q]M1/K=;/.[7P"Z>^J!#^XR,+1R=^+PRZ/SCJ<(C4JVM?T#U"(/C/ M-^[;[YZ\)_RAWX7J@G'1@JX-._2_(4 M]73?%(_JALYT__D+4P'Y)-P]&5"AH+L^B7^JQK^,9_\58/"S>-_E"T%N$2JW MQ1U?D!D^:Q31NP&EVSWR[ZFTJ]\!>[=2;5N$1J!B=Z(Z!ZA"W!@1"<71EIJC M ?O[6>V[:X/CG-/JK]/^^LHW_#S==5MMOU^9ZR&QAL2ZKVSNA%AOSF4Z535/ M;D>SG;$]^K4MOT>U]\[$4XRQQJSL\Z,]I=96KV4FRI[XX,8X->24]<^]QE;/X?>8DBL=T.LH;=X?NU"T?@%:3"' M*D7#BI^ !@,ASTRXW1?\06C%WJP5>V95<#N]K^[9I=QG)OBS#M /"4--[/'4 M"2M7GN?E);489MN=^@"0]6)IU9$3DH!\3(JG(S3*XI^_CV;(FC?/FE?V,J\Z MS_J\_N9OLB9%EEKBLE@>3('(-=:2QHCYU0JR)G1 8[$($WNO0_8].Y^^>9 : MR\8(((]R*&L6L91U%[=307B$VX!>*>Y)I*G .J_%<&WK]:M:[6'F\JZ#V[A; MGL>T>2,#6?89<6QUF-KR:VJ?74](O$&ZD*2:15MH:].\J:1CN4IL,9+BR!CA MA'B$IR\9[OYZY/]UV?[VO/J?CLZ\-^\>M^:-#F2O=^!N%/GY0L$/3J7W[3Y< M/T5\D8AN2',W3'/73XR>,S![(\Z8X#EC>&(4? D4ZJ'%=><6UT/G\AXHIML MMF-I"NYS"OE.7",C"IQPG QA*C=7HY8@RNPFO:IR1ZJ]84@+>>8C?EO/^@(%^// M'O&]GD51G:,#A+7"MVN97RL>>SM2Y]S#D#XO#HLEC<]B-5TVWA8Z4U#CYB^5 M##^5U4R5X]F^T>9QVV0&"1TZSH4)X)!G;]CM_F2>O8BI$L\2[LR4Q'F]4Y; MB_42R0HSD4@5#S)$A@(C1/@3,X4>(Q[![^6&[5?EQK8-'!M7DNF:C D_+#T. M_9S;#E>$I<+T?_]3+7R84!8(=ZA,+*$!;HB[XH=U[LW;O0V4N M[[/^)PAWY0W% K(-TL#[_[P1L%)CRTFGAG.OXO5Q.4DQ4\T4XU&X.;/_DD"# M=J ?RI.1.$.&=UV_)D>&#N;98M$?9,XW;\564MTY+Q9Z]?9BDAIJ%6Z44N.8 M2Z'G&:?0M?2?SM&^4\_3MPNJSAA8ES *KFVY?E6+/2P[?I3(]\^%7,)0,?_N MA-V[/0!:O?0Z_:SK@.0YNC^V)L/A&%U+U!L8FVNN):%[A-Y$>30J?@*3D68:;Z@OO5Y+0V& '*6 MZF>R NV;P&SVGN*MI=*9W+)A.%/>Z<_AL?EQ2$#;Z'B%9@('6/#K/279-OK MUWC?=_.KW^;5(]M8%-2T.*)C;5!(S[+S8MZ2J01B4=0@"]K&9/PX$O @[;%> MIPCF\@9/R8T2MCN?ZQJPSF=$?#UK^#:\@(?..C^"]8%K9MYV]6L>3S8#ACPA MPN++I!!]SBQSI"P55M-)KZ19.2C"8CCEP) 1DGZOXC9D[*_.V+?GM=^M??+K MW/RF\]"HRHX[+F45LMABBEV)U@8,7T=L[971G\A0_+%=OG0O[ES_R:L9WC<,DK$QZ4=KP9!VNV0MKV_O2<4$YUDMBL. MUI1(N_U&:J3WQNT^%(JXTQH5X1@Z0G&7++?\>CSR=65#&"3Y'+/H3+*A-DWW M*H93FD\WS^U<(;54N]7U"LD&:#"Q'!LAJ>.[A?<=/\'6D8;FX0+;"1VSK^"8 MW5C;"].>"]<]P !@:#4@[# $AAN>(7A F;]P+148$6][W^GYFO"-G5- M)?Z+Q/]Y=+B\&1*X-ER^5L@@X/2&Q^COV?T#M\/7C(Y=%U/S093D&U D;J!0 MQ#T$&3X>H4YT @HC J'H^ H1@\>Y#$&SW@L&!R]8 71@N$==_<>;XYU"(SW; MJ'E[WB"V,00BL1WI^?_^/0B3F+_&ZK?$U^6/+E#N>?$^_&ZWQTLZW5E.R62PP4[C9"Q=P>SP9>/ 38'$$O-%O#Y$*80+QT O%(5-5\9D13AIR$H8H!/YZ0 M63G&B?4TT%M,-[V7WDC-4LHR/I)HW(HM%N'HL"U[R-9ASO 6+)!?86N%JB:F M8G]3)8L])SZR)QV!'B<06^-4H2!PT7BW/%- MLGN,YP0FT[XH.+*:O.]%=3!T\(8^L>KJ2PC$!S_D+634KU4U^."H_2+T>_WL M_"TJ%1'KS3LHC MS=(.E 1R+SJ>6A!]37&J^&O4KR:&PW6J/4V-Y^Q((9]?,EI"8G#7J7B$H?D( MQ3_X\.P&F'M):Z1*:[4:H9N0 T*C]LZ-VAOJ+_7@29&+9DNWW&E7AVDP.%4V MLE$%5YV;&V::U3LUFS:M34Q,H/V@SM%D/$+'PF1HR."/Z=X^3A>H4^IXB .D M0"54S0**8UK>G(CA4%. 16Bƹ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end